FR3004641A1 - COSMETIC COMPOSITION COMPRISING A CUCURBIC ACID COMPOUND AND OXYALKYLENE POLY (POLY) OIL - Google Patents
COSMETIC COMPOSITION COMPRISING A CUCURBIC ACID COMPOUND AND OXYALKYLENE POLY (POLY) OIL Download PDFInfo
- Publication number
- FR3004641A1 FR3004641A1 FR1353508A FR1353508A FR3004641A1 FR 3004641 A1 FR3004641 A1 FR 3004641A1 FR 1353508 A FR1353508 A FR 1353508A FR 1353508 A FR1353508 A FR 1353508A FR 3004641 A1 FR3004641 A1 FR 3004641A1
- Authority
- FR
- France
- Prior art keywords
- ppg
- ether
- butyl ether
- composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 140
- -1 CUCURBIC ACID COMPOUND Chemical class 0.000 title claims abstract description 53
- LYSGIJUGUGJIPS-VWYCJHECSA-N UNPD204931 Natural products CCC=CC[C@@H]1[C@@H](O)CC[C@@H]1CC(O)=O LYSGIJUGUGJIPS-VWYCJHECSA-N 0.000 title claims abstract description 12
- LYSGIJUGUGJIPS-UHFFFAOYSA-N beta-Cucurbic acid Natural products CCC=CCC1C(O)CCC1CC(O)=O LYSGIJUGUGJIPS-UHFFFAOYSA-N 0.000 title claims abstract description 12
- FRUCUWUFGHVLGX-GUBZILKMSA-N cucurbic acid Natural products CCC=C/C[C@@H]1[C@@H](O)CC[C@@H]1C(=O)O FRUCUWUFGHVLGX-GUBZILKMSA-N 0.000 title claims abstract description 12
- 239000002537 cosmetic Substances 0.000 title description 12
- 239000000839 emulsion Substances 0.000 claims abstract description 13
- 102000011782 Keratins Human genes 0.000 claims abstract description 9
- 108010076876 Keratins Proteins 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 9
- 239000007762 w/o emulsion Substances 0.000 claims abstract 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 claims description 36
- 125000004432 carbon atom Chemical group C* 0.000 claims description 32
- 150000001875 compounds Chemical class 0.000 claims description 17
- 229930195733 hydrocarbon Natural products 0.000 claims description 12
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 claims description 11
- 239000004215 Carbon black (E152) Substances 0.000 claims description 11
- RAFYDKXYXRZODZ-UHFFFAOYSA-N octanoyl octanoate Chemical compound CCCCCCCC(=O)OC(=O)CCCCCCC RAFYDKXYXRZODZ-UHFFFAOYSA-N 0.000 claims description 11
- ZQCIPRGNRQXXSK-UHFFFAOYSA-N 1-octadecoxypropan-2-ol Chemical compound CCCCCCCCCCCCCCCCCCOCC(C)O ZQCIPRGNRQXXSK-UHFFFAOYSA-N 0.000 claims description 10
- 229940078491 ppg-15 stearyl ether Drugs 0.000 claims description 10
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 229920006395 saturated elastomer Chemical group 0.000 claims description 8
- AXMWVEOITAQHFI-UHFFFAOYSA-N 2-(3-hydroxy-2-pentylcyclopentyl)acetic acid Chemical compound CCCCCC1C(O)CCC1CC(O)=O AXMWVEOITAQHFI-UHFFFAOYSA-N 0.000 claims description 7
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 claims description 6
- 229940116987 ppg-3 myristyl ether Drugs 0.000 claims description 5
- 150000003254 radicals Chemical class 0.000 claims description 5
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- RHEFZZHALQVVFD-UHFFFAOYSA-N 3-octadec-9-enoxypropan-1-ol Chemical compound CCCCCCCCC=CCCCCCCCCOCCCO RHEFZZHALQVVFD-UHFFFAOYSA-N 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 229940023565 ppg-10 cetyl ether Drugs 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- WGYZMNBUZFHYRX-UHFFFAOYSA-N 1-(1-methoxypropan-2-yloxy)propan-2-ol Chemical compound COCC(C)OCC(C)O WGYZMNBUZFHYRX-UHFFFAOYSA-N 0.000 claims description 2
- LORVPHHKJFSORQ-UHFFFAOYSA-N 1-[1-(1-butoxypropan-2-yloxy)propan-2-yloxy]propan-2-ol Chemical compound CCCCOCC(C)OCC(C)OCC(C)O LORVPHHKJFSORQ-UHFFFAOYSA-N 0.000 claims description 2
- HANWHVWXFQSQGJ-UHFFFAOYSA-N 1-tetradecoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCCCCCC HANWHVWXFQSQGJ-UHFFFAOYSA-N 0.000 claims description 2
- GVZNXUAPPLHUOM-UHFFFAOYSA-N 2-[1-(1-methoxypropan-2-yloxy)propan-2-yloxy]propan-1-ol Chemical compound COCC(C)OCC(C)OC(C)CO GVZNXUAPPLHUOM-UHFFFAOYSA-N 0.000 claims description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 2
- AQMHNCQZLQUNJI-UHFFFAOYSA-N [CH2]CCCCCC Chemical group [CH2]CCCCCC AQMHNCQZLQUNJI-UHFFFAOYSA-N 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 2
- 125000005702 oxyalkylene group Chemical group 0.000 claims description 2
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 claims description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 2
- 229940096956 ppg-11 stearyl ether Drugs 0.000 claims description 2
- 229940078492 ppg-17 Drugs 0.000 claims description 2
- 229940089994 ppg-2 methyl ether Drugs 0.000 claims description 2
- XXBAQTDVRLRXEV-UHFFFAOYSA-N 3-tetradecoxypropan-1-ol Chemical compound CCCCCCCCCCCCCCOCCCO XXBAQTDVRLRXEV-UHFFFAOYSA-N 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 42
- 239000003921 oil Substances 0.000 description 40
- 235000019198 oils Nutrition 0.000 description 38
- 235000014113 dietary fatty acids Nutrition 0.000 description 23
- 239000000194 fatty acid Substances 0.000 description 23
- 229930195729 fatty acid Natural products 0.000 description 23
- 229920005862 polyol Polymers 0.000 description 22
- 235000011187 glycerol Nutrition 0.000 description 17
- 210000003491 skin Anatomy 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 15
- 150000004665 fatty acids Chemical class 0.000 description 15
- 150000003077 polyols Chemical class 0.000 description 13
- LYSGIJUGUGJIPS-UOMVISFLSA-N (+)-cucurbic acid Chemical class CC\C=C/C[C@@H]1[C@@H](O)CC[C@@H]1CC(O)=O LYSGIJUGUGJIPS-UOMVISFLSA-N 0.000 description 10
- 239000003995 emulsifying agent Substances 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 229920001296 polysiloxane Polymers 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 159000000000 sodium salts Chemical class 0.000 description 8
- 239000001993 wax Substances 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 7
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 150000002430 hydrocarbons Chemical class 0.000 description 6
- 229920000223 polyglycerol Polymers 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 5
- JKHBSEMWNFTGPM-UHFFFAOYSA-N CCCCCCCCCCCCCCOCC(C)OCC(C)OCC(C)O Chemical compound CCCCCCCCCCCCCCOCC(C)OCC(C)OCC(C)O JKHBSEMWNFTGPM-UHFFFAOYSA-N 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 229940008099 dimethicone Drugs 0.000 description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical compound CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 235000014121 butter Nutrition 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- YCOZIPAWZNQLMR-UHFFFAOYSA-N heptane - octane Natural products CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 4
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 3
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 229940100460 peg-100 stearate Drugs 0.000 description 3
- 229940100518 polyglyceryl-4 isostearate Drugs 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical class CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical class CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical class NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 2
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000007957 coemulsifier Substances 0.000 description 2
- 239000004567 concrete Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- 229940102552 disteardimonium hectorite Drugs 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- NDJKXXJCMXVBJW-UHFFFAOYSA-N heptadecane Chemical compound CCCCCCCCCCCCCCCCC NDJKXXJCMXVBJW-UHFFFAOYSA-N 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid group Chemical group C(CCCCCC)(=O)O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Chemical class 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- AFBUJPLSNNUUBE-UHFFFAOYSA-N octan-4-yl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CCC)CCCC AFBUJPLSNNUUBE-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 229940057429 sorbitan isostearate Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical class [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019160 vitamin B3 Nutrition 0.000 description 2
- 239000011708 vitamin B3 Substances 0.000 description 2
- 239000003021 water soluble solvent Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- NRTKYSGFUISGRQ-UHFFFAOYSA-N (3-heptanoyloxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC NRTKYSGFUISGRQ-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- QFGCFKJIPBRJGM-UHFFFAOYSA-N 12-[(2-methylpropan-2-yl)oxy]-12-oxododecanoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCC(O)=O QFGCFKJIPBRJGM-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- JSOVGYMVTPPEND-UHFFFAOYSA-N 16-methylheptadecyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)(C)C JSOVGYMVTPPEND-UHFFFAOYSA-N 0.000 description 1
- RWKSBJVOQGKDFZ-UHFFFAOYSA-N 16-methylheptadecyl 2-hydroxypropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)O RWKSBJVOQGKDFZ-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical class NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- FWIUBOWVXREPPL-UHFFFAOYSA-N 2-[2-(7-methyloctanoyloxy)ethoxy]ethyl 7-methyloctanoate Chemical compound CC(C)CCCCCC(=O)OCCOCCOC(=O)CCCCCC(C)C FWIUBOWVXREPPL-UHFFFAOYSA-N 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-hydroxyoctadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- QENRKQYUEGJNNZ-UHFFFAOYSA-N 2-methyl-1-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound CC(C)C(S(O)(=O)=O)NC(=O)C=C QENRKQYUEGJNNZ-UHFFFAOYSA-N 0.000 description 1
- MWYGSCHWFNRSET-UHFFFAOYSA-N 2-pentylcyclopentan-1-ol Chemical compound CCCCCC1CCCC1O MWYGSCHWFNRSET-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- YHCCCMIWRBJYHG-UHFFFAOYSA-N 3-(2-ethylhexoxymethyl)heptane Chemical compound CCCCC(CC)COCC(CC)CCCC YHCCCMIWRBJYHG-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 108010087765 Antipain Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000454552 Astrocaryum murumuru Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- STLQHNXQJVMKIG-UHFFFAOYSA-N C(C)(=O)O.C(CCCC)C1CCCC1 Chemical compound C(C)(=O)O.C(CCCC)C1CCCC1 STLQHNXQJVMKIG-UHFFFAOYSA-N 0.000 description 1
- PMNFKWDIHABHSL-LNKPDPKZSA-N C(C)(=O)O.OC1C(CCC1)C\C=C/CC Chemical compound C(C)(=O)O.OC1C(CCC1)C\C=C/CC PMNFKWDIHABHSL-LNKPDPKZSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 240000009226 Corylus americana Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- OVBJJZOQPCKUOR-UHFFFAOYSA-L EDTA disodium salt dihydrate Chemical compound O.O.[Na+].[Na+].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O OVBJJZOQPCKUOR-UHFFFAOYSA-L 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 240000007930 Oxalis acetosella Species 0.000 description 1
- 235000008098 Oxalis acetosella Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 229920002517 Poloxamer 338 Polymers 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 241000907903 Shorea Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- SDNYTAYICBFYFH-TUFLPTIASA-N antipain Chemical compound NC(N)=NCCC[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SDNYTAYICBFYFH-TUFLPTIASA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- OHXVIZBSLGZEFS-UHFFFAOYSA-N benzhydrylsilyloxy-diphenyl-silyloxysilane Chemical class C1(=CC=CC=C1)C(C1=CC=CC=C1)[SiH2]O[Si](O[SiH3])(C1=CC=CC=C1)C1=CC=CC=C1 OHXVIZBSLGZEFS-UHFFFAOYSA-N 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 229940067573 brown iron oxide Drugs 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 125000005534 decanoate group Chemical class 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical class CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical group [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- ANXXYABAFAQBOT-UHFFFAOYSA-N dodecyl-methyl-bis(trimethylsilyloxy)silane Chemical compound CCCCCCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C ANXXYABAFAQBOT-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000003659 hair regrowth Effects 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical class [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- LTYSCLBTUYRCBF-UHFFFAOYSA-N icosan-9-yl 2-hydroxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)OC(CCCCCCCC)CCCCCCCCCCC LTYSCLBTUYRCBF-UHFFFAOYSA-N 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- RNNBHZYEKNHLKT-UHFFFAOYSA-N isopropylmethylpyrazolyl dimethylcarbamate Chemical compound CC(C)N1N=C(C)C=C1OC(=O)N(C)C RNNBHZYEKNHLKT-UHFFFAOYSA-N 0.000 description 1
- ASKIVFGGGGIGKH-UHFFFAOYSA-N isostearic acid monoglyceride Natural products CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical class [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229940094933 n-dodecane Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 125000005474 octanoate group Chemical class 0.000 description 1
- 125000005473 octanoic acid group Chemical class 0.000 description 1
- YBGZDTIWKVFICR-UHFFFAOYSA-N octinoxate Chemical compound CCCCC(CC)COC(=O)C=CC1=CC=C(OC)C=C1 YBGZDTIWKVFICR-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- HRPZGPXWSVHWPB-UHFFFAOYSA-N octyl decanoate Chemical compound CCCCCCCCCC(=O)OCCCCCCCC HRPZGPXWSVHWPB-UHFFFAOYSA-N 0.000 description 1
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940031709 peg-30-dipolyhydroxystearate Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical class OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical group [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001921 poly-methyl-phenyl-siloxane Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000001966 tensiometry Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
L'invention concerne une composition notamment sous forme d'émulsion en particulier eau-dans huile comprenant un composé d'acide cucurbique et une huile polaire (poly)oxyalkylénée (C3-C4). Application au soin et au maquillage des matières kératiniques.The invention relates to a composition, especially in the form of an emulsion, in particular a water-in-oil emulsion, comprising a cucurbic acid compound and a polar (poly) oxyalkylenated (C3-C4) oil. Application to the care and makeup of keratin materials.
Description
Composition cosmétique comprenant un composé d'acide cucurbique et une huile polaire (poly)oxyalkylénée La présente invention concerne des compositions notamment cosmétiques et/ou dermatologiques comprenant un composé d'acide cucurbique et une huile polaire (poly)oxyalkylénée en C3-C4, ainsi que l'utilisation de ces compositions dans un procédé de traitement non thérapeutique des matières kératiniques en particulier d'êtres humains. Plus particulièrement, les compositions de l'invention sont destinées au soin et/ou au maquillage des matières kératiniques. Au sens de l'invention, on entend désigner par « matières kératiniques », par exemple, la peau, les muqueuses, les lèvres, le cuir chevelu, les fibres kératiniques telles que les cils, les sourcils et les cheveux.Cosmetic composition comprising a cucurbic acid compound and a (poly) oxyalkylenated (polar) polar oil The present invention relates to especially cosmetic and / or dermatological compositions comprising a cucurbic acid compound and a (poly) oxyalkylenated (C 3 -C 4) polar oil, and that the use of these compositions in a method of non-therapeutic treatment of keratin materials, in particular human beings. More particularly, the compositions of the invention are intended for caring for and / or making up keratin materials. For the purposes of the invention, the term "keratin materials" is intended to mean, for example, the skin, the mucous membranes, the lips, the scalp, the keratinous fibers such as eyelashes, eyebrows and hair.
Il est connu dans la demande EP-A-1333021 des composés d'acide cucurbique comme l'acide 3-hydroxy-2-pentyl-cyclopentane acétique pour favoriser la desquamation de la peau et stimuler le renouvellement épidermique, lutter contre les signes du vieillissement cutané, améliorer l'éclat du teint et/ou lisser la peau du visage. Dans la demande FR-A62921255 ces composés sont également décrits pour leur utilisation comme agent dépigmentant. Toutefois, l'introduction de ces composés précédemment cités dans des formulations cosmétiques sous forme d'émulsion, en particulier d'émulsion huile-dans-eau, peut altérer fortement la stabilité des compositions les comprenant, pouvant se traduire par exemple par une diminution non négligeable de la viscosité et/ou un déphasage de la composition. Cependant les compositions contenant des dérivés de l'acide cucurbique présentent des propriétés cosmétiques insuffisantes, notamment un toucher collant, effet rêche, ce qui donne des compositions qui sont peu agréables à appliquer par un consommateur. Par ailleurs, les dérivés de l'acide cucurbique présentent également l'inconvénient d'être peu solubles, Il s'en suit une recristallisation de ces dérivés ce qui entraine une instabilité des formulations. Les dérivés de l'acide cucurbique ne sont alors plus disponibles pour agir sur la peau. Il est connu d'utiliser dans les préparations cosmétiques contenant de l'acide cucurbique ou ses dérivés des huiles et des émollients qui ont pour rôle d'assouplir, d'adoucir, d'hydrater et d'améliorer le confort de la peau.It is known in the application EP-A-1333021 cucurbic acid compounds such as 3-hydroxy-2-pentyl-cyclopentane acetic acid to promote desquamation of the skin and stimulate epidermal renewal, fight against the signs of aging skin, improve the radiance of the complexion and / or smooth the skin of the face. In the application FR-A62921255 these compounds are also described for their use as a depigmenting agent. However, the introduction of these compounds mentioned above into cosmetic formulations in the form of an emulsion, in particular of an oil-in-water emulsion, can greatly impair the stability of the compositions comprising them, which can result, for example, in a decrease negligible viscosity and / or phase shift of the composition. However compositions containing derivatives of cucurbic acid have insufficient cosmetic properties, including a sticky feel, rough effect, resulting in compositions that are unappealing to be applied by a consumer. Moreover, the derivatives of cucurbic acid also have the disadvantage of being poorly soluble, It follows a recrystallization of these derivatives which causes instability of the formulations. The derivatives of cucurbic acid are then no longer available to act on the skin. It is known to use in cosmetics containing cucurbic acid or its derivatives oils and emollients whose role is to soften, soften, moisturize and improve the comfort of the skin.
Cependant ces huiles ne permettent pas de maintenir la stabilité des dérivés d'acide cucurbique tout en ayant de bonnes propriétés cosmétiques. Ainsi, il existe un besoin de disposer de compositions comprenant des composés d'acide cucurbique, qui soient stables et qui présentent de bonne propriétés cosmétiques, notamment un toucher dont la texture est non grasse, non collante. De manière surprenante, les inventeurs ont observé que l'utilisation d'un composé d'acide cucurbique en association avec une huile polaire particulière permet de réaliser de tels objectifs. Plus précisément, la présente invention concerne une composition comprenant dans un milieu physiologiquement acceptable : - au moins un composé d'acide cucurbique, notamment de formule (I) suivante : (I) dans laquelle : R1 représente un radical COOR3, R3 désignant un atome d'hydrogène ou un radical alkyle en C1-C4 , éventuellement substitué par un ou plusieurs groupes hydroxyle ; R2 représente un radical hydrocarboné, saturé ou insaturé, linéaire ayant de 1 à 18 atomes de carbones, ou ramifié ou cyclique ayant de 3 à 18 atomes de carbone ; ainsi que leurs isomères optiques, et sels correspondants et - au moins une huile polaire (poly)oxyalkylénée en C3-C4 Les compositions obtenues présentent une bonne stabilité dans le temps, un aspect agréable, et lors de leur application, de bonnes propriétés sensorielles. Par « composition stable », on entend une composition qui, après 24 heures de stockage à toutes températures comprises entre 4°C et 50°C, ne présente peu 15 ou pas de changement macroscopique de couleur, d'odeur ou de viscosité. Selon encore un autre de ses objets, la présente invention concerne un procédé de traitement non thérapeutique de soin ou de maquillage des matières kératiniques comprenant l'application sur lesdites matières 20 kératiniques d'une composition conforme à l'invention. Composé d'acide cucurbique. Le composé dérivé d'acide cucurbique est un composé choisi parmi ceux 25 répondant à la formule (I) suivante : (I) dans laquelle : R1 représente un radical COOR3, R3 désignant un atome d'hydrogène ou un radical alkyle en C1-C4 , éventuellement substitué par un ou plusieurs groupes hydroxyle ; R2 représente un radical hydrocarboné, saturé ou insaturé, linéaire ayant de 1 à 18 atomes de carbones, ou ramifié ou cyclique ayant de 3 à 18 atomes de carbone ; ainsi que leurs isomères optiques, et sels correspondants.However, these oils do not make it possible to maintain the stability of the cucurbic acid derivatives while having good cosmetic properties. Thus, there is a need for compositions comprising cucurbic acid compounds, which are stable and which have good cosmetic properties, especially a touch whose texture is non-greasy, non-sticky. Surprisingly, the inventors have observed that the use of a cucurbic acid compound in combination with a particular polar oil makes it possible to achieve such objectives. More specifically, the present invention relates to a composition comprising in a physiologically acceptable medium: at least one cucurbic acid compound, in particular of formula (I) below: wherein: R1 represents a radical COOR3, R3 denoting an atom hydrogen or a C1-C4 alkyl radical, optionally substituted with one or more hydroxyl groups; R2 represents a hydrocarbon radical, saturated or unsaturated, linear having 1 to 18 carbon atoms, or branched or cyclic having 3 to 18 carbon atoms; as well as their optical isomers, and corresponding salts and - at least one (poly) oxyalkylenated (C 3 -C 4) polar oil The compositions obtained exhibit good stability over time, a pleasant appearance, and, when they are applied, good sensory properties. By "stable composition" is meant a composition which, after 24 hours storage at all temperatures between 4 ° C and 50 ° C, shows little or no macroscopic change in color, odor or viscosity. According to yet another of its objects, the present invention relates to a method of non-therapeutic treatment care or makeup of keratin materials comprising the application on said keratin materials of a composition according to the invention. Cucurbic acid compound. The compound derived from cucurbic acid is a compound chosen from those corresponding to the following formula (I): (I) in which: R1 represents a COOR3 radical, R3 denoting a hydrogen atom or a C1-C4 alkyl radical; optionally substituted with one or more hydroxyl groups; R2 represents a hydrocarbon radical, saturated or unsaturated, linear having 1 to 18 carbon atoms, or branched or cyclic having 3 to 18 carbon atoms; as well as their optical isomers, and corresponding salts.
De préférence, R1 désigne un radical choisi parmi -COOH, -COOMe, -000- CH2-CH3, -COO-CH2-CH(OH)-CH2OH, -COOCH2-CH2-CH2OH , - COOCH2-CH(OH)-CH3 . Préférentiellement, R1 désigne un radical -COOH.Preferably, R1 denotes a radical chosen from -COOH, -COOMe, -000-CH2-CH3, -COO-CH2-CH (OH) -CH2OH, -COOCH2-CH2-CH2OH, -COOCH2-CH (OH) -CH3 . Preferentially, R 1 denotes a -COOH radical.
Préférentiellement, R2 désigne un radical hydrocarboné, linéaire, saturé ou insaturé, et de préférence ayant de 2 à 7 atomes de carbone. En particulier, R2 peut être un radical pentyl, pentenyl, hexyle, heptyle. Selon un mode de réalisation, le composé de formule (I) est choisi parmi l'acide 3-hydroxy-2-[(2Z)-2-penteny1]-cyclopentane acétique ou l'acide 3-hydroxy-2-pentyl-cyclopentane acétique. De préférence, le composé (I) est l'acide 3-hydroxy-2-pentyl-cyclopentane acétique ; ce composé peut être notamment sous la forme de sel de sodium.Preferably, R2 denotes a hydrocarbon radical, linear, saturated or unsaturated, and preferably having from 2 to 7 carbon atoms. In particular, R2 may be a pentyl, pentenyl, hexyl or heptyl radical. According to one embodiment, the compound of formula (I) is chosen from 3-hydroxy-2 - [(2Z) -2-pentenyl] -cyclopentane acetic acid or 3-hydroxy-2-pentylcyclopentane acid. acetic. Preferably, the compound (I) is 3-hydroxy-2-pentylcyclopentane acetic acid; this compound may especially be in the form of sodium salt.
Les sels des composés utilisables selon l'invention sont en particulier choisis parmi les sels de métal alcalin, par exemple sodium, potassium ; les sels de métal alcalino-terreux, par exemple calcium, magnésium, strontium, les sels métalliques, par exemple zinc, aluminium, manganèse, cuivre ; les sels d'ammonium de formule NH4; les sels d'ammonium quaternaires ; les sels d'amines organiques, comme par exemple les sels de méthylamine, de diméthylamine, de triméthylamine, de triéthylamine, d'éthylamine, de 2- hydroxyéthylam ine, de bis-(2-hydroxyéthyl)amine, de la tri-(2- hydroxyéthyl)amine ; les sels de lysine, d'arginine. On utilise de préférence les sels choisis parmi les sels de sodium, potassium, magnésium, strontium, cuivre, manganèse, zinc. Préférentiellement, on utilise le sel de sodium. Le composé dérivé d'acide cucurbique de formule (I) défini précédemment peut être présent dans la composition selon l'invention en une teneur allant de 0,01 à 15 % en poids, par rapport au poids total de la composition, de préférence de 0,1 à 10 % en poids et mieux de 0,5 à 5% en poids. Huile polaire (polv)oxyalkylénée en C3-C4 Par huile polaire au sens de la présente invention, on entend une huile dont la tension superficielle correspond à la force par unité de longueur, exprimée en mN/m est supérieure à 20mN/m. Ces huiles peuvent être de natures chimiques différentes telle que : des esters, des éthers, des alcanes, des alcools, des alcènes, des huiles végétales, d'origine naturelle ou synthétique, hydrocarbonés ou silicones, linéaires ou ramifiés, polymérisés ou non. Selon l'invention, les huiles (poly)oxyalkylénées en C3-C4 ne comprennent généralement pas de groupements oxyéthylénés. L'huile polaire selon l'invention a une tension superficielle supérieure à 15mN/m, mieux supérieure à 20 mN/M et préférentiellement supérieure à 25 mN/m et plus particulièrement allant de 25 à 40 mN/m. Méthode de mesure de la Tension de surface Tensiométrie La tension superficielle est mesurée selon les méthodes classiques, notamment selon la méthode de la goutte pendante et plus particulièrement selon la méthode de l'anneau de Du Noüy. La technique de l'anneau de Du Noüy consiste à plonger un anneau de platine dans le liquide dont on cherche à mesurer la tension de surface puis à exercer une traction sur l'anneau vers l'interface liquide/air à température ambiante. Le tensiomètre va rechercher la force maximale à cette interface et la mesurer (figure k). Cette force s'écrit Pm et ne s'obtient pas directement ; elle subit une 10 correction selon la géométrie de l'anneau. L'appareil calculera d'abord g$* appelé tension de surface mesurée. Elle s'obtient par la relation : gs* = Pm / [2p(Ri + Ro)] ; avec Ri et Ro les rayons respectivement intérieur et extérieur de l'anneau. Puis, il en déduira gs d'après la relation : gs = gs*.F ; où F est le facteur correcteur dépendant de la densité du liquide ainsi que du rapport des 15 diamètres de l'anneau. 20 On effectue la manipulation avec un tensiomètre Krüss K12, le liquide est disposé dans un cristallisoir parfaitement nettoyé (cristallisoir de 46mm de diamètre ref GL5 de Kruss) et l'anneau est en platine irridié (ref R101 de 25 Kruss). L'appareil donne directement la tension superficielle en mN/m.The salts of the compounds that may be used according to the invention are in particular chosen from alkali metal salts, for example sodium and potassium; alkaline earth metal salts, for example calcium, magnesium, strontium, metal salts, for example zinc, aluminum, manganese, copper; ammonium salts of formula NH4; quaternary ammonium salts; organic amine salts, such as, for example, the salts of methylamine, dimethylamine, trimethylamine, triethylamine, ethylamine, 2-hydroxyethylamine, bis- (2-hydroxyethyl) amine, tri- - hydroxyethyl) amine; lysine salts, arginine. Salts chosen from among the sodium, potassium, magnesium, strontium, copper, manganese and zinc salts are preferably used. Preferably, the sodium salt is used. The cucurbic acid derivative compound of formula (I) defined above may be present in the composition according to the invention in a content ranging from 0.01 to 15% by weight, relative to the total weight of the composition, preferably from 0.1 to 10% by weight and more preferably 0.5 to 5% by weight. C3-C4 oxyalkylene-polar oil (polv) Polar oil within the meaning of the present invention means an oil whose surface tension corresponds to the force per unit length, expressed in mN / m, is greater than 20 mN / m. These oils can be of different chemical natures such as: esters, ethers, alkanes, alcohols, alkenes, vegetable oils, of natural or synthetic origin, hydrocarbon or silicone, linear or branched, polymerized or not. According to the invention, the (poly) oxyalkylenated C 3 -C 4 oils generally do not comprise oxyethylenated groups. The polar oil according to the invention has a surface tension greater than 15 mN / m, better still greater than 20 mN / m and preferably greater than 25 mN / m and more particularly ranging from 25 to 40 mN / m. Surface Voltage Measurement Method Tensiometry The surface tension is measured according to conventional methods, in particular according to the method of the hanging drop and more particularly according to the method of the Du Noüy ring. The technique of the Du Noüy ring consists of dipping a platinum ring into the liquid whose surface tension is to be measured and then exerting traction on the ring towards the liquid / air interface at ambient temperature. The monitor will search for the maximum force at this interface and measure it (Figure k). This force is written Pm and can not be obtained directly; it undergoes a correction according to the geometry of the ring. The device will first calculate g $ * called measured surface tension. It is obtained by the relation: gs * = Pm / [2p (Ri + Ro)]; with Ri and Ro respectively the inner and outer rays of the ring. Then he will deduce gs from the relation: gs = gs * .F; where F is the correction factor depending on the density of the liquid as well as the ratio of the diameters of the ring. The handling is carried out with a Krüss K12 tensiometer, the liquid is placed in a perfectly cleaned crystallizer (crystallizer 46mm in diameter ref GL5 Kruss) and the ring is platinum iridium (ref R101 Kruss). The device gives the surface tension directly in mN / m.
L'huile polaire selon l'invention est de préférence un composé (poly)oxyalkéné de formule (I): R-0(AO)nH (I) dans laquelle R représente un radical alkyl ou acyle, linéaire ou ramifié, saturé ou insaturé en C1-C22, de préférence en C3-C18; AO représente un groupe oxyalkyléné comprenant de 3 à 4 atomes de carbone, et de préférence 3, n représente le nombre moyen de moles d'unités AO et n va de 1 à 100, de préférence de 3 à 50 et plus particulièrement de 5 à 20. De préférence, R est un radical alkyle en C1-C22, mieux en C3-C18. L'huile polaire (poly)oxyalkylénée selon l'invention est de préférence choisie parmi PPG-2 Butyl Ether ; PPG-3 Butyl Ether ; PPG-4 Butyl Ether ; PPG-5 Butyl Ether ; PPG-9 Butyl Ether ; PPG-12 Butyl E ther ; PPG-14 Butyl Ether ;PPG-15 Butyl Ether ;PPG-16 Butyl Ether ; PPG-17 Butyl Ether ; PPG-18 Butyl Ether ; PPG-20 Butyl Ether ; PPG-22 Butyl Ether ; PPG-24 Butyl Ether ; PPG-26 Butyl Ether ; PPG-30 Butyl Ether ; PPG-33 Butyl Ether ; PPG-40 Butyl Ether ; PPG- 52 Butyl Ether ; PPG-53 Butyl Ether ; PPG-3 Caprylyl Ether ; PPG-4 Caprylyl Ether ; PPG-5 Caprylyl Ether ; PPG-6 Caprylyl Ether ; PPG-10 Caprylyl Ether ; PPG-10 Cetyl Ether ;PPG-20 Cetyl éther ; PPG-28 Cetyl Ether ; PPG-30 Cetyl Ether ; PPG-50 Cetyl Ether ; PPG-4 Lauryl Ether ; PPG-7 Lauryl Ether ; PPG10 Lauryl Ether ;PPG-2 Methyl Ether ;PPG-3 Methyl Ether ; PPG-4 Methyl Ether ;PPG-3 Myristyl Ether ; PPG-4 Myristyl Ether ;PPG-10 Oleyl Ether ;PPG- 20 Oleyl Ether ;PPG-23 Oleyl Ether ; PPG-30 Oleyl Ether ; PPG-37 Oleyl Ether ; PPG-50 Oleyl Ether ; PPG-11 Stearyl Ether ; PPG-15 Stearyl Ether et leurs mélanges. (PPG signifie PolyPropylene Glycol)30 De préférence, l'huile polaire (poly)oxyalkylénée selon l'invention est le PPG15 Stearyl éther, le PPG-3 Myristyl Ether, le PPG-12 Butyl Ether, PPG-10 Caprylyl Ether ; PPG-10 Cetyl Ether ;PPG-20 Cetyl éther, PPG-10 Oleyl Ether ;PPG-20 Oleyl Ether ;PPG-23 Oleyl Ether et plus particulièrement le PPG-15 Stearyl Ether et le PPG-3 myristyl Ether, encore mieux le PPG-15 Stearyl Ether. L'huile polaire (poly)oxyalkylénée en C3-C4 est généralement présente dans les compositions selon l'invention à une teneur pouvant aller de 0,1 % à 20 % en poids, par rapport au poids total de la composition, et de préférence de 0,5 % à 10% en poids, et mieux de 1 à 5% en poids par rapport au poids total de la composition. Les compositions utilisées selon l'invention comprennent un milieu 15 physiologiquement acceptable, c'est-à-dire compatible avec les matières kératiniques d'êtres humains tels que la peau , le cuir chevelu, les cheveux, les ongles. Les compositions selon l'invention peuvent se présenter sous forme de 20 solutions aqueuses, de solutions hydroalcooliques, d'émulsions huile-dans-eau (H/E) ou eau-dans-huile (E/H) ou multiple (triple : E/H/E ou H/E/H), de gels aqueux. Les compositions peuvent également être anhydres. Ces compositions sont préparées selon les méthodes usuelles. 25 Le milieu physiologiquement acceptable peut comprendre de l'eau, des solvants organiques tels qu'un alcool en C1-C8, notamment l'éthanol, l'isopropanol, le tert-butanol, le n-butanol; un polyol tel que la glycérine ; un glycol comme le butylène glycol, l'isoprène glycol, le propylène glycol, les polyéthylène glycols tels que le PEG-8 ; les éthers de polyol. 30 Lorsque la composition est une émulsion, la proportion de la phase grasse peut aller de 5% à 80% en poids, et de préférence de 5% à 50% en poids par rapport au poids total de la composition. Les huiles, les cires, les émulsionnants et les coémulsionnants utilisés dans la composition sous forme d'émulsion sont choisis parmi ceux classiquement utilisés dans le domaine cosmétique. L'émulsionnant et le coémulsionnant sont présents, dans la composition, en une proportion allant de 0,3% à 30% en poids, et de préférence de 0,5 à 20% en poids par rapport au poids total de la composition. L'émulsion peut, en outre, contenir des vésicules lipidiques.The polar oil according to the invention is preferably a (poly) oxyalkene compound of formula (I): R-O (AO) nH (I) in which R represents an alkyl or acyl radical, linear or branched, saturated or unsaturated C1-C22, preferably C3-C18; AO represents an oxyalkylene group comprising from 3 to 4 carbon atoms, and preferably 3, n represents the average number of moles of AO units and n ranges from 1 to 100, preferably from 3 to 50 and more particularly from 5 to 20. Preferably, R is a C1-C22 alkyl radical, more preferably a C3-C18 alkyl radical. The (poly) oxyalkylenated polar oil according to the invention is preferably chosen from PPG-2 butyl ether; PPG-3 butyl ether; PPG-4 butyl ether; PPG-5 butyl ether; PPG-9 butyl ether; PPG-12 butyl ether; PPG-14 Butyl Ether, PPG-15 Butyl Ether, PPG-16 Butyl Ether; PPG-17 Butyl Ether; PPG-18 Butyl Ether; PPG-20 butyl ether; PPG-22 Butyl Ether; PPG-24 Butyl Ether; PPG-26 Butyl Ether; PPG-30 Butyl Ether; PPG-33 Butyl Ether; PPG-40 butyl ether; PPG-Butyl Ether; PPG-53 Butyl Ether; PPG-3 Caprylyl Ether; PPG-4 Caprylyl Ether; PPG-5 Caprylyl Ether; PPG-6 Caprylyl Ether; PPG-10 Caprylyl Ether; PPG-10 Cetyl Ether, PPG-20 Cetyl Ether; PPG-28 Cetyl Ether; PPG-30 Cetyl Ether; PPG-50 Cetyl Ether; PPG-4 Lauryl Ether; PPG-7 Lauryl Ether; PPG10 Lauryl Ether, PPG-2 Methyl Ether, PPG-3 Methyl Ether; PPG-4 Methyl Ether PPG-3 Myristyl Ether; PPG-4 Myristyl Ether, PPG-10 Oleyl Ether, PPG-Oleyl Ether, PPG-23 Oleyl Ether; PPG-30 Oleyl Ether; PPG-37 Oleyl Ether; PPG-50 Oleyl Ether; PPG-11 Stearyl Ether; PPG-15 Stearyl Ether and mixtures thereof. (PPG is PolyPropylene Glycol) Preferably, the (poly) oxyalkylenated (polar) polar oil according to the invention is PPG15 Stearyl Ether, PPG-3 Myristyl Ether, PPG-12 Butyl Ether, PPG-10 Caprylyl Ether; PPG-10 Cetyl Ether, PPG-20 Cetyl Ether, PPG-10 Oleyl Ether, PPG-20 Oleyl Ether, PPG-23 Oleyl Ether and more particularly PPG-15 Stearyl Ether and PPG-3 Myristyl Ether, even better PPG -15 Stearyl Ether. The polar (poly) oxyalkylenated C 3 -C 4 oil is generally present in the compositions according to the invention at a content ranging from 0.1% to 20% by weight, relative to the total weight of the composition, and preferably from 0.5% to 10% by weight, and more preferably from 1 to 5% by weight relative to the total weight of the composition. The compositions used according to the invention comprise a physiologically acceptable medium, that is to say compatible with the keratin materials of human beings such as the skin, the scalp, the hair, the nails. The compositions according to the invention may be in the form of aqueous solutions, hydroalcoholic solutions, oil-in-water (O / W) or water-in-oil (W / O) or multiple (triple: E) emulsions. / H / E or H / E / H), aqueous gels. The compositions can also be anhydrous. These compositions are prepared according to the usual methods. The physiologically acceptable medium may comprise water, organic solvents such as a C1-C8 alcohol, especially ethanol, isopropanol, tert-butanol, n-butanol; a polyol such as glycerine; a glycol such as butylene glycol, isoprene glycol, propylene glycol, polyethylene glycols such as PEG-8; polyol ethers. When the composition is an emulsion, the proportion of the fatty phase may range from 5% to 80% by weight, and preferably from 5% to 50% by weight relative to the total weight of the composition. The oils, the waxes, the emulsifiers and the coemulsifiers used in the composition in emulsion form are chosen from those conventionally used in the cosmetics field. The emulsifier and the coemulsifier are present in the composition in a proportion ranging from 0.3% to 30% by weight, and preferably from 0.5% to 20% by weight relative to the total weight of the composition. The emulsion may further contain lipid vesicles.
Lorsque la composition est une solution ou un gel huileux, la phase grasse peut représenter plus de 90% du poids total de la composition. La composition selon l'invention peut comporter une quantité de phase aqueuse qui peut aller par exemple de 30 à 97 % en poids, de préférence de 15 40 à 95 % en poids et mieux de 50 à 90 % en poids par rapport au poids total de la composition. La phase aqueuse comprend de l'eau et tout autre composé hydrosoluble éventuellement présent, tels que notamment les solvants et additifs hydrosolubles (par exemple tensioactifs hydrophiles et actifs). 20 Comme solvants hydrosolubles, on peut citer notamment les alcools inférieurs et les polyols. On entend par alcool inférieur, les alcools comportant de 1 à 8 et plus particulièrement de 1 à 6 atomes de carbone, tels que l'éthanol. Comme polyols, on peut citer par exemple la glycérine, le propylène glycol, le butylène 25 glycol et les polyéthylène glycols (PEG-8 par exemple). Ces alcools et/ou polyols peuvent être présents dans la composition en une quantité allant de préférence de 0,1 à 25 % et de 1 à 15 % du poids total de la composition. La composition comprend une phase grasse qui comprend au moins l'huile 30 polaire selon l'invention.When the composition is a solution or an oily gel, the fatty phase may represent more than 90% of the total weight of the composition. The composition according to the invention may comprise an amount of aqueous phase which may range, for example, from 30 to 97% by weight, preferably from 40 to 95% by weight and better still from 50 to 90% by weight relative to the total weight. of the composition. The aqueous phase comprises water and any other water-soluble compound that may be present, such as, in particular, water-soluble solvents and additives (for example hydrophilic and active surfactants). As water-soluble solvents, there may be mentioned in particular lower alcohols and polyols. The term "lower alcohol" is understood to mean alcohols containing from 1 to 8 and more particularly from 1 to 6 carbon atoms, such as ethanol. As polyols, mention may be made, for example, of glycerine, propylene glycol, butylene glycol and polyethylene glycols (PEG-8 for example). These alcohols and / or polyols may be present in the composition in an amount ranging preferably from 0.1 to 25% and from 1 to 15% of the total weight of the composition. The composition comprises a fatty phase which comprises at least the polar oil according to the invention.
La phase grasse est constituée des huiles et de tous les autres corps gras et constituants lipophiles pouvant être présents dans la composition de l'invention. Toutes les huiles cosmétiquement acceptables peuvent être utilisées.The fatty phase consists of oils and all the other fatty substances and lipophilic constituents that may be present in the composition of the invention. All cosmetically acceptable oils can be used.
On entend par "huile" un corps gras liquide à température ambiante (25°C) et pression atmosphérique. Comme huile, on peut citer par exemple : - les huiles hydrocarbonées d'origine animale, telles que le perhydrosqualène et le squalane ; - les huiles hydrocarbonées d'origine végétale, telles que les triglycérides liquides d'acides gras comportant de 4 à 10 atomes de carbone comme les triglycérides des acides heptanoïque ou octanoïque ou encore, par exemple les huiles de tournesol, de maïs, de soja, de courge, de pépins de raisin, de sésame, de noisette, d'abricot, de macadamia, d'arara, de tournesol, de ricin, d'avocat, les triglycérides des acides caprylique/caprique comme ceux vendus par la société Stearineries Dubois ou ceux vendus sous les dénominations Miglyol 810, 812 et 818 par la société Dynamit Nobel, l'huile de jojoba, l'huile de beurre de karité ; - les esters et les éthers de synthèse, notamment d'acides gras, comme les huiles de formules R1COOR2 et R10R2 dans laquelle R1 représente le reste d'un acide gras comportant de 8 à 29 atomes de carbone, et R2 représente une chaîne hydrocarbonée, ramifiée ou non, contenant de 3 à 30 atomes de carbone, comme par exemple l'huile de Purcellin, l'isononanoate d'isononyle, le myristate d'isopropyle, le palmitate d'éthy1-2-hexyle, le stéarate d'octy1-2- dodécyle, l'érucate d'octy1-2-dodécyle, l'isostéarate d'isostéaryle ; les esters hydroxyles comme l'isostéaryl lactate, l'octylhydroxystéarate, l'hydroxystéarate d'octyldodécyle, le diisostéaryl-malate, le citrate de triisocétyle, les heptanoates, octanoates, décanoates d'alcools gras ; les esters de polyol, comme le dioctanoate de propylène glycol, le diheptanoate de néopentylglycol et le diisononanoate de diéthylèneglycol ; et les esters du pentaérythritol comme le tétraisostéarate de pentaérythrityle (Prisorine 3631) ; - les hydrocarbures linéaires ou ramifiés, d'origine minérale ou synthétique, tels que les huiles de paraffine, volatiles ou non, et leurs dérivés, la vaseline, les polydécènes, le polyisobutène hydrogéné tel que l'huile de Parléam ; - les alcanes linéaires volatils, avantageusement d'origine végétale, comprenant de 7 à 17 atomes de carbone, en particulier de 9 à 15 atomes de carbone, et plus particulièrement de 11 à 13 atomes de carbone. A titre d'exemples d'alcanes linéaires volatils convenant à l'invention, on peut mentionner ceux décrits dans la demande de brevet de la société Cognis WO 2007/068371. A titre d'exemple d'alcane linéaire volatil convenant à l'invention, on peut citer le n-nonane (C9), le n-décane (C10), le n-undécane (C11), le ndodécane (C12), le n-tridécane (C13), le n-tétradecane (C14), le n-pentadécane (C15), le n-héxadécane (C16) et le n-heptadécane (C17) et leurs mélanges. Selon un mode de réalisation, on utilisera un mélange d'undécane (C11) et de tridécane (C13) comme obtenu aux exemples 1 et 2 de la demande W02008/155059 de la Société Cognis. On peut également citer le n-dodécane (C12) et le n-tétradécane (C14) tels que ceux vendus par Sasol respectivement sous les références PARAFOL 12-97 et PARAFOL 14-97, ainsi que leurs mélanges. - les huiles de silicone, comme par exemple les polyméthylsiloxanes (PDMS) volatiles ou non à chaîne siliconée linéaire ou cyclique, liquides ou pâteux à température ambiante, notamment les cyclopolydiméthylsiloxanes (cyclométhicones) telles que la cyclohexasiloxane et la cyclopentasiloxane ; les polydiméthylsiloxanes (ou diméthicones) comportant des groupements alkyle, alcoxy ou phényle, pendant ou en bout de chaîne siliconée, groupements ayant de 2 à 24 atomes de carbone ; les silicones phénylées comme les phényltriméthicones, les phényldiméthicones, les phényltriméthylsiloxydiphényl-siloxanes, les diphényl-diméthicones, les diphénylméthyldiphényl trisiloxanes, les 2-phényléthyltriméthyl-siloxysilicates, et les polyméthylphénylsiloxanes ; - les alcools gras ayant de 8 à 26 atomes de carbone, comme l'alcool cétylique, l'alcool stéarylique et leur mélange (alcool cétylstéarylique) ; - les huiles fluorées partiellement hydrocarbonées et/ou siliconées comme celles décrites dans le document JP-A-2-295912 ; - et leurs mélanges. On peut citer également les huiles choisies parmi : - les esters issus de la réaction d'au moins un acide gras comportant au moins 6 atomes de carbone, de préférence de 6 à 26 atomes de carbone et mieux de 6 à 20 atomes de carbone, encore mieux de 6 à 16 atomes de carbone et d'au moins un alcool comprenant de 1 à 17 atomes de carbone et mieux de 3 à 15 atomes de carbone ; on peut citer notamment le myristate d'isopropyle, le palmitate d' isopropyle le caprate/caprylate d'ethy12-hexyle (ou caprate/caprylate d'octyle), le palmitate d'éthy1-2-hexyle, le néopentanoate d'isostéaryle, l'isononanoate d'isononyle, le laurate d'hexyle, les esters d'acide lactique et d'alcools gras comprenant 12 ou 13 atomes de carbone, le carbonate de dicaprylyle tel que celui qui est commercialisé sous la dénomination CETIOL CC par la société COGNIS, - les éthers d'acide gras comprenant de 6 à 20 atomes de carbone tel que le dicaprylyl éther (Cetiol OE de Cognis), - les éthers de glycérol comprenant de 6 à 12 atomes de carbone comme le 2- éthyl hexyle éther de glycérol ( nom INCI ethylhexylglycerin) tel que le Sensiva SC 50 de la société Schulke & Mayr GmbH, La phase grasse peut être présente dans la composition selon l'invention en une quantité allant de 5 à 60 %, mieux allant de 5 à 50 % et de préférence de 10 à 40 % en poids par rapport au poids total de la composition. Cette quantité n'inclue pas l'émulsionnant ester d'acide gras polyhydroxylé et de polyalkylène glycol. En particulier, la composition selon l'invention peut comprendre de 5 à 40 % et de préférence de 10 à 30 % en poids d'huiles par rapport au poids total de la composition.The term "oil" means a fatty substance that is liquid at ambient temperature (25 ° C.) and atmospheric pressure. As oil, there may be mentioned, for example: hydrocarbon-based oils of animal origin, such as perhydrosqualene and squalane; hydrocarbon-based oils of vegetable origin, such as liquid triglycerides of fatty acids containing from 4 to 10 carbon atoms, for instance triglycerides of heptanoic or octanoic acids or, for example, sunflower, corn or soybean oils, squash, grape seed, sesame, hazelnut, apricot, macadamia, arara, sunflower, castor oil, avocado, triglycerides of caprylic / capric acids such as those sold by Stearineries Dubois or those sold under the names Miglyol 810, 812 and 818 by the company Dynamit Nobel, jojoba oil, shea butter oil; esters and synthetic ethers, in particular of fatty acids, such as the oils of formulas R 1 COOR 2 and R 10 R 2 in which R 1 represents the residue of a fatty acid comprising from 8 to 29 carbon atoms, and R 2 represents a hydrocarbon-based chain, branched or unbranched, containing from 3 to 30 carbon atoms, such as, for example, purcellin oil, isononyl isononanoate, isopropyl myristate, ethyl-2-hexyl palmitate, octyl stearate, Dodecyl, octy-2-dodecyl erucate, isostearyl isostearate; hydroxyl esters such as isostearyl lactate, octyl hydroxystearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate, heptanoates, octanoates, decanoates of fatty alcohols; polyol esters, such as propylene glycol dioctanoate, neopentyl glycol diheptanoate and diethylene glycol diisononanoate; and pentaerythritol esters such as pentaerythrityl tetraisostearate (Prisorine 3631); linear or branched hydrocarbons of mineral or synthetic origin, such as paraffin oils, volatile or not, and their derivatives, petroleum jelly, polydecenes, hydrogenated polyisobutene such as Parleam oil; volatile linear alkanes, advantageously of plant origin, comprising from 7 to 17 carbon atoms, in particular from 9 to 15 carbon atoms, and more particularly from 11 to 13 carbon atoms. As examples of volatile linear alkanes that are suitable for the invention, mention may be made of those described in the patent application of Cognis WO 2007/068371. By way of example of a volatile linear alkane which is suitable for the invention, mention may be made of n-nonane (C9), n-decane (C10), n-undecane (C11), ndodecane (C12), n-tridecane (C13), n-tetradecane (C14), n-pentadecane (C15), n-hexadecane (C16) and n-heptadecane (C17), and mixtures thereof. According to one embodiment, use will be made of a mixture of undecane (C11) and tridecane (C13) as obtained in Examples 1 and 2 of Application WO2008 / 155059 from Cognis. Mention may also be made of n-dodecane (C12) and n-tetradecane (C14), such as those sold by Sasol respectively under the references PARAFOL 12-97 and PARAFOL 14-97, as well as their mixtures. silicone oils, for example volatile or non-volatile polymethylsiloxanes (PDMSs) with a linear or cyclic silicone chain, which are liquid or pasty at room temperature, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclohexasiloxane and cyclopentasiloxane; polydimethylsiloxanes (or dimethicones) comprising alkyl, alkoxy or phenyl groups, during or at the end of the silicone chain, groups having from 2 to 24 carbon atoms; phenyl silicones such as phenyltrimethicones, phenyldimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyl-dimethicones, diphenylmethyldiphenyltrisiloxanes, 2-phenylethyltrimethylsiloxysilicates, and polymethylphenylsiloxanes; fatty alcohols having from 8 to 26 carbon atoms, such as cetyl alcohol, stearyl alcohol and their mixture (cetylstearyl alcohol); partially fluorinated hydrocarbon oils and / or silicone oils such as those described in document JP-A-2-295912; - and their mixtures. Mention may also be made of oils chosen from: esters derived from the reaction of at least one fatty acid comprising at least 6 carbon atoms, preferably from 6 to 26 carbon atoms and better still from 6 to 20 carbon atoms, more preferably from 6 to 16 carbon atoms and from at least one alcohol comprising from 1 to 17 carbon atoms and more preferably from 3 to 15 carbon atoms; mention may be made in particular of isopropyl myristate, isopropyl palmitate, ethy12-hexyl caprate / caprylate (or octyl caprate / caprylate), ethyl-2-hexyl palmitate, isostearyl neopentanoate, isononyl isononanoate, hexyl laurate, esters of lactic acid and of fatty alcohols comprising 12 or 13 carbon atoms, dicaprylyl carbonate, such as that marketed under the name CETIOL CC by the company COGNIS, - fatty acid ethers comprising from 6 to 20 carbon atoms, such as dicaprylyl ether (Cetiol OE from Cognis), - glycerol ethers containing from 6 to 12 carbon atoms, such as 2-ethyl hexyl ether, glycerol (INCI name ethylhexylglycerin) such as Sensiva SC 50 from Schulke & Mayr GmbH, the fatty phase may be present in the composition according to the invention in an amount ranging from 5 to 60%, better still from 5 to 50% and preferably from 10 to 40% by weight relative to the total weight al of the composition. This amount does not include the polyhydroxy fatty acid ester and polyalkylene glycol ester emulsifier. In particular, the composition according to the invention may comprise from 5 to 40% and preferably from 10 to 30% by weight of oils relative to the total weight of the composition.
En plus des huiles indiquées ci-dessus, la composition de l'invention peut contenir d'autres corps gras dans la phase grasse, tels que les acides gras comportant de 8 à 30 atomes de carbone, comme l'acide stéarique ; les résines de silicone telles que la trifluorométhyl-C1-4-alkyldimethicone et la trifluoropropyldimethicone ; les gommes de silicone (dimethiconol), les élastomères de silicone non émulsionnants, comme les produits commercialisés sous les dénominations « KSG 6» ou « KSG 16» par la société Shin-Etsu, sous les dénominations « Trefil », « BY29 » ou « EPSX » par la société Dow Corning ou sous les dénominations « Gransil » par la société Grant Industries ; les cires, par exemple les cires minérales, les cires d'origine animale comme la cire d'abeille, les cires d'origine végétale, les huiles hydrogénées concrètes à 25°C, les esters gras et les glycérides concrets à 25°C, les cires synthétiques, les cires de silicone ; les corps gras pâteux comme et aussi les beurres tels que le beurre de karité, le beurre de cacao, le beurre de shorea, le beurre de muru muru, le beurre de cupuac, et leurs mélanges. Emulsionnants Selon un mode de réalisation, la composition selon l'invention peut comprendre un ou plusieurs émulsionnant (ou tensioactif). L'émulsionnant peut être choisi par exemple parmi les émulsionnants non ioniques dérivés d'acide gras et de polyol, les polyoléfines à terminaison succinique, et leurs mélanges. Comme polyoléfines à terminaison succinique, on peut citer notamment les polyisobutylènes à terminaison succinique estérifiée et leurs sels, notamment les sels de diéthanolamine, tels que les produits commercialisés sous les dénominations Lubrizol 2724, Lubrizol 2722 et Lubrizol 5603 par la société Lubrizol.In addition to the oils mentioned above, the composition of the invention may contain other fatty substances in the fatty phase, such as fatty acids having from 8 to 30 carbon atoms, such as stearic acid; silicone resins such as trifluoromethyl-C1-4-alkyldimethicone and trifluoropropyldimethicone; silicone gums (dimethiconol), non-emulsifying silicone elastomers, such as the products sold under the names "KSG 6" or "KSG 16" by the company Shin-Etsu, under the names "Trefil", "BY29" or " EPSX "by Dow Corning or under the names" Gransil "by Grant Industries; waxes, for example mineral waxes, waxes of animal origin, such as beeswax, waxes of plant origin, hydrogenated oils which are concretes at 25 ° C., fatty esters and concrete glycerides at 25 ° C. synthetic waxes, silicone waxes; pasty fatty substances as and also butters such as shea butter, cocoa butter, shorea butter, muru muru butter, cupuac butter, and mixtures thereof. Emulsifiers According to one embodiment, the composition according to the invention may comprise one or more emulsifier (or surfactant). The emulsifier may be chosen for example from nonionic emulsifiers derived from fatty acid and polyol, succinic-terminated polyolefins, and mixtures thereof. As succinically terminated polyolefins, mention may be made in particular of esterified succinic-terminated polyisobutylenes and their salts, in particular the diethanolamine salts, such as the products sold under the names Lubrizol 2724, Lubrizol 2722 and Lubrizol 5603 by the company Lubrizol.
De préférence, l'émulsionnant est choisi parmi les esters d'acide gras et de polyols.Preferably, the emulsifier is chosen from fatty acid esters and polyols.
Par 'esters d'acide gras et de polyols' selon l'invention, on entend des esters d'acide gras et de polyol dans lesquels l'acide gras comprend une chaîne alkyle en C6-C22, de préférence en C16-C20, et le polyol est choisi parmi le glycérol, un polyglycérol, le sorbitan, et leurs mélanges. L'acide gras peut également être sous une forme polymérique, comme c'est le cas de l'acide polyhydroxystéarique (polymère de l'acide 1 2-hydroxystéarique). Selon un mode particulier, l'ester d'acide gras et de polyol est un ester d'acide gras en C16-C20 et de glycérol et/ou de sorbitan, et leurs mélanges. Comme exemples d'acides gras à chaîne linéaire ou ramifiée en C15-C20, on 15 peut citer l'acide stéarique, l'acide isostéarique, l'acide laurique, l'acide myristique, l'acide palmitique. Comme exemple de polymère d'acide gras en C15-C20, on peut citer l'acide poly12-hydroxystéarique. De préférence on utilisera l'acide stéarique, isostéarique, l'acide poly1 2- hydroxystéarique et leurs mélanges. 20 Par polyglycérols, on entend des composés de formule dans laquelle le degré de condensation n va de 1 à 11, de préférence de 2 à 6 et encore plus préférentiellement de 3 à 6. 25 Selon un mode particulier, l'ester d'acide gras et de polyol contient 2 à 10 moles (unités) de polyols, de préférence 2 à 4 moles de polyols, en particulier 2 à 4 unités de glycérol ou un mélange de polyglycérols (glycérol, di-, tri-, tetra, penta-, oligoglycerols).The term "fatty acid and polyol esters" according to the invention is understood to mean fatty acid and polyol esters in which the fatty acid comprises a C 6 -C 22, preferably C 16 -C 20, alkyl chain, and the polyol is selected from glycerol, a polyglycerol, sorbitan, and mixtures thereof. The fatty acid can also be in a polymeric form, as is the case of polyhydroxystearic acid (1 2-hydroxystearic acid polymer). In a particular embodiment, the fatty acid and polyol ester is a C 16 -C 20 fatty acid ester and glycerol and / or sorbitan, and mixtures thereof. Examples of C15-C20 linear or branched chain fatty acids include stearic acid, isostearic acid, lauric acid, myristic acid, palmitic acid. As an example of a C15-C20 fatty acid polymer, mention may be made of poly12-hydroxystearic acid. Preferably, stearic acid, isostearic acid, poly-1-hydroxystearic acid and mixtures thereof are used. By polyglycerols is meant compounds of formula in which the degree of condensation n is from 1 to 11, preferably from 2 to 6 and even more preferably from 3 to 6. According to a particular embodiment, the acid ester fatty acid and polyol contains 2 to 10 moles (units) of polyols, preferably 2 to 4 moles of polyols, in particular 2 to 4 units of glycerol or a mixture of polyglycerols (glycerol, di-, tri-, tetra, penta , oligoglycerols).
Encore plus préférentiellement, l'ester d'acide gras et de polyol contient 4 moles cou unités) de poltol, en particulier 4 moles (ou unités) de glycérol. Selon un mode préféré, ledit ester d'acide gras et de polyol est en outre un ester d'acide gras, de diacide carboxylique ayant de 2 à 16 atomes de carbone, de préférence de 8 à 14 atomes de carbone, tels que l'acide azélaïque, l'acide sébacique, l'acide dodecanedioique, et de préférence l'acide sébacique (C10), et de polyol.Even more preferably, the fatty acid and polyol ester contains 4 mole (neck) units of poltol, in particular 4 moles (or units) of glycerol. According to a preferred embodiment, said fatty acid and polyol ester is, in addition, a fatty acid ester of a dicarboxylic acid having 2 to 16 carbon atoms, preferably 8 to 14 carbon atoms, such as azelaic acid, sebacic acid, dodecanedioic acid, and preferably sebacic acid (C10), and polyol.
A titre d'exemples d'esters d'acide gras et de polyol utilisables dans la composition de l'invention, on peut citer les esters d'acide isostéarique et de polyols et leurs mélanges, en particulier les esters d'acide isostéarique et de glycérol et/ou de sorbitan, tels que par exemple l'isostéarate polyglycérolé (4 moles) (nom INCI : Polyglycery1-4 Isostearate) vendu sous la dénomination Isolan GI34® par la société Goldschmidt, le diisostéarate polyglycérolé (3 moles) vendu sous la dénomination Lameform TGI® par la société Cognis ; le distéarate polyglycérolé (2 moles) vendu sous la dénomination Emalex PGSA® par la société Nihon emulsion ; le monoisostearate polyglycérolé (10 moles) vendu sous la dénomination Nikkol decaglyn 1-15 par la société Nihon Surfactant (Nom INCI : Polyglyceryl-10 isostearate) ; le polyglycéry1-4 diisostéarate polyhydroxystéarate sébacate vendu sous la dénomination ISOLAN GPS par Goldschmidt ; le mélange d"isostéarate de sorbitan et d'isostéarate de glycérol, tel que le produit commercialisé sous la dénomination Arlacel 986 par la société ICI, le mélange d'isostéarate de sorbitan et d'isostéarate de polyglycérol (3 moles) commercialisé sous la dénomination Arlacel 1690 par la société Uniquema, le mélange d'isostéarate de sorbitan et d'isostéarate de polyglycérol (3 moles) commercialisé sous la dénomination Arlacel 1690® par la société Uniquema et leurs mélanges.As examples of fatty acid and polyol esters that may be used in the composition of the invention, mention may be made of isostearic acid and polyol esters and their mixtures, in particular esters of isostearic acid and of glycerol and / or sorbitan, such as polyglycerol isostearate (4 moles) (INCI name: Polyglyceryl-4 Isostearate) sold under the name Isolan GI34® by Goldschmidt, polyglyceryl diisostearate (3 moles) sold under the name Lameform TGI® denomination by Cognis; polyglycerolated distearate (2 moles) sold under the name Emalex PGSA® by the Nihon emulsion company; polyglycerol monoisostearate (10 moles) sold under the name Nikkol decaglyn 1-15 by the company Nihon Surfactant (INCI name: Polyglyceryl-10 isostearate); polyglyceryl 4-diisostearate polyhydroxystearate sebacate sold under the name ISOLAN GPS by Goldschmidt; the mixture of sorbitan isostearate and glycerol isostearate, such as the product sold under the name Arlacel 986 by the company ICI, the mixture of isostearate of sorbitan and polyglyceryl isostearate (3 moles) marketed under the name Arlacel 1690 by the company Uniquema, the mixture of sorbitan isostearate and polyglycerol isostearate (3 moles) sold under the name Arlacel 1690® by the company Uniquema and their mixtures.
On peut également citer les tensioactifs silicones tels que les dimethicone copolyols et alkyl dimethicone copolyols tels que le mélange de cyclomethicone et de dimethicone copolyol, vendu sous la dénomination « DC 5225 C » par la société Dow Corning, le Laurylmethicone copolyol vendu sous la dénomination "Dow Corning 5200 Formulation Aid" par la société Dow Corning et le Cetyl dimethicone copolyol vendu sous la dénomination Abil EM 9OR par la société Goldschmidt. De préférence, l'émulsionnant est choisi parmi les esters d'acide gras, de préférence en C15-C20, en particulier l'acide stéarique ou l'acide isostéarique, et de polyol choisi parmi le glycérol et/ou le sorbitan.Mention may also be made of silicone surfactants such as dimethicone copolyols and alkyl dimethicone copolyols such as the mixture of cyclomethicone and dimethicone copolyol, sold under the name "DC 5225 C" by Dow Corning, and Laurylmethicone copolyol sold under the name " Dow Corning 5200 Formulation Aid "by Dow Corning and Cetyl dimethicone copolyol sold under the name Abil EM 9 OR by Goldschmidt. Preferably, the emulsifier is chosen from fatty acid esters, preferably C15-C20, in particular stearic acid or isostearic acid, and polyol chosen from glycerol and / or sorbitan.
L'émulsionnant peut être présente une teneur (en matières sèches) allant de 0,05 à 5 % en poids par rapport au poids total de la composition, de préférence de 0,1 à 3 % en poids par rapport au poids total de la composition.The emulsifier may be present in a content (of solids) ranging from 0.05 to 5% by weight relative to the total weight of the composition, preferably from 0.1 to 3% by weight relative to the total weight of the composition. composition.
Additifs De façon connue, la composition pour application topique de l'invention peut contenir également un ou plusieurs des adjuvants habituels dans le domaine cosmétique ou dermatologique. Comme adjuvants, on peut citer par les épaississants, les actifs, les conservateurs, les antioxydants, les parfums, les solvants, les sels, les charges, les filtres solaires (= filtres U.V.) minéraux ou organiques, les matières colorantes, les agents basiques (triéthanolamine, diéthanolamine, hydroxyde de sodium) ou acides (acide citrique), et leurs mélanges. Ces adjuvants sont utilisés dans les proportions habituelles dans le domaine cosmétique, et par exemple de 0,01 à 30 % du poids total de la composition, et ils sont, selon leur nature, introduits dans la phase aqueuse de la composition ou dans la phase huileuse, ou encore dans des vésicules ou tout autre type de vecteur. Ces adjuvants ainsi que leurs concentrations doivent être tels qu'ils ne modifient pas les propriétés recherchées pour la composition de l'invention.Additives In known manner, the composition for topical application of the invention may also contain one or more adjuvants usual in the cosmetic or dermatological field. As adjuvants, mention may be made of thickeners, active agents, preservatives, antioxidants, perfumes, solvents, salts, fillers, sunscreens (= UV filters), inorganic or organic, dyestuffs, basic agents. (triethanolamine, diethanolamine, sodium hydroxide) or acids (citric acid), and mixtures thereof. These adjuvants are used in the usual proportions in the cosmetics field, and for example from 0.01 to 30% of the total weight of the composition, and they are, according to their nature, introduced into the aqueous phase of the composition or into the phase oily, or in vesicles or any other type of vector. These adjuvants and their concentrations must be such that they do not modify the properties desired for the composition of the invention.
Selon la viscosité désirée pour la composition selon l'invention, on peut y incorporer un ou plusieurs épaississants hydrophiles. On peut citer par exemple les polymères carboxyvinyliques modifiés ou non, tels que les produits commercialisés sous les dénominations Carbopol (nom INCI : carbomer) par la société Noveon ; les polyacrylam ides ; les polymères et copolymères d'acide 25 acrylamido 2-méthylpropane sulfonique, éventuellement réticulés et/ou neutralisés, comme le poly(acide 2-acrylamido 2-méthylpropane sulfonique) commercialisé par la société Clariant sous la dénomination « Hostacerin AMPS » (nom INCI: ammonium polyacryldimethyltauramide) ; les copolymères anioniques réticulés d'acrylamide et d'AMPS, se présentant sous la forme 10 d'une émulsion E/H, tels ceux commercialisés sous le nom de SEPIGEL 305 (nom C.T.F.A. : Polyacrylamide / C13-14 Isoparaffin / Laureth-7) et sous le nom de SIMULGEL 600 (nom C.T.F.A. : Acrylam ide / Sodium acryloyldimethyltaurate copolymer / Isohexadecane / Polysorbate 80) par la société SEPPIC ; les biopolymères polysaccharidiques comme la gomme de 15 xanthane, la gomme guar, les alginates, les celluloses modifiées ou non ; et leurs mélanges. Quand ils sont présents, ces gélifiants doivent être introduits en quantité telle qu'ils ne modifient pas les propriétés de la composition selon l'invention. Comme gélifiants lipophiles, on peut citer notamment les argiles modifiées telles que le silicate de magnésium modifié (bentone gel V538 de 20 RHEOX), l'hectorite modifiée par le chlorure de distéaryl diméthyl ammonium (nom INCI : Disteardimonium hectorite) commercialisé sous la dénomination « bentone 38 CE » par la société RHEOX. Comme actifs utilisables dans la composition de l'invention, on peut citer par 25 exemple, les agents hydratants tels que les hydrolysats de protéines ; le hyaluronate de sodium ; les polyols comme la glycérine, les glycols comme les polyéthylène glycols, et les dérivés de sucre ; les anti-inflammatoires ; les oligomères procyannidoliques ; les vitamines comme la vitamine A (rétinol), la vitamine E (tocophérol), la vitamine K, la vitamine C (acide ascorbique), la 30 vitamine B5 (panthénol), la vitamine B3 ou PP (niacinamide), les dérivés de ces vitamines (notamment esters) et leurs mélanges ; les agents kératolytiques et/ou desquamants tels que l'acide salicylique et ses dérivés, les alphahydroxyacides comme l'acide lactique et l'acide glycolique et leurs dérivés, l'acide ascorbique et ses dérivés ; l'urée ; la caféine ; les dépigmentants tels que l'acide kojique, l'hydroquinone et l'acide caféique ; l'acide salicylique et ses dérivés ; les rétinoïdes tels que les caroténoïdes et les dérivés de vitamine A; l'hydrocortisone ; la mélatonine ; les agents autobronzants tels que la DHA, les extraits d'algues, de champignons, de végétaux, de levures, de bactéries ; les stéroïdes ; les actifs anti-bactériens comme le 2,4,4'-trichloro-2'-hydroxy diphényl éther (ou triclosan), le 3,4,4'-trichlorocarbanilide (ou triclocarban) et les acides indiqués ci-dessus et notamment l'acide salicylique et ses dérivés ; les enzymes ; les flavonoïdes ; les agents tenseurs tels que les polymères synthétiques, les protéines végétales, les polysaccharides d'origine végétale, les amidons, les dispersions de cires, les silicates mixtes et les particules colloïdales de charges inorganiques ; les céramides ; les agents anti- inflammatoires ; les agents apaisants ; les agents matifiants ; les agents anti- chute et/ou repousse des cheveux ; les agents anti-rides ; les huiles essentielles ; et leurs mélanges ; et tout actif approprié pour le but final de la composition.Depending on the viscosity desired for the composition according to the invention, one or more hydrophilic thickeners may be incorporated therein. Mention may be made, for example, of modified or unmodified carboxyvinyl polymers, such as the products sold under the names Carbopol (INCI name: carbomer) by the company Noveon; polyacrylamides; polymers and copolymers of acrylamido-2-methylpropanesulphonic acid, optionally crosslinked and / or neutralized, such as poly (2-acrylamido-2-methylpropanesulphonic acid) marketed by Clariant under the name "Hostacerin AMPS" (INCI name: ammonium polyacryldimethyltauramide); crosslinked anionic copolymers of acrylamide and AMPS, in the form of an W / O emulsion, such as those marketed under the name SEPIGEL 305 (CTFA name: Polyacrylamide / C13-14 Isoparaffin / Laureth-7) and under the name SIMULGEL 600 (CTFA name: Acrylamide / Sodium acryloyldimethyltaurate copolymer / Isohexadecane / Polysorbate 80) by the company SEPPIC; polysaccharide biopolymers such as xanthan gum, guar gum, alginates, modified or unmodified celluloses; and their mixtures. When they are present, these gelling agents must be introduced in such a quantity that they do not modify the properties of the composition according to the invention. As lipophilic gelling agents, mention may in particular be made of modified clays such as modified magnesium silicate (RHEOX bentone gel V538), hectorite modified with distearyl dimethyl ammonium chloride (INCI name: Disteardimonium hectorite) sold under the name " bentone 38 CE "by RHEOX. As active agents that can be used in the composition of the invention, mention may be made, for example, of moisturizing agents such as protein hydrolysates; sodium hyaluronate; polyols such as glycerin, glycols such as polyethylene glycols, and sugar derivatives; anti-inflammatories; procyannidol oligomers; vitamins such as vitamin A (retinol), vitamin E (tocopherol), vitamin K, vitamin C (ascorbic acid), vitamin B5 (panthenol), vitamin B3 or PP (niacinamide), derivatives thereof vitamins (especially esters) and mixtures thereof; keratolytic and / or desquamating agents such as salicylic acid and its derivatives, alphahydroxyacids such as lactic acid and glycolic acid and their derivatives, ascorbic acid and its derivatives; urea; caffeine; depigmenting agents such as kojic acid, hydroquinone and caffeic acid; salicylic acid and its derivatives; retinoids such as carotenoids and vitamin A derivatives; hydrocortisone; melatonin; self-tanning agents such as DHA, extracts of algae, fungi, plants, yeasts, bacteria; steroids; anti-bacterial active agents such as 2,4,4'-trichloro-2'-hydroxy diphenyl ether (or triclosan), 3,4,4'-trichlorocarbanilide (or triclocarban) and the acids indicated above, and in particular the salicylic acid and its derivatives; enzymes; flavonoids; tensing agents such as synthetic polymers, plant proteins, polysaccharides of vegetable origin, starches, wax dispersions, mixed silicates and colloidal particles of inorganic fillers; ceramides; anti-inflammatory agents; soothing agents; mattifying agents; anti-hair loss agents and / or hair regrowth; anti-wrinkle agents; essential oils ; and their mixtures; and any suitable asset for the ultimate purpose of the composition.
Une composition de l'invention peut se présenter sous toutes les formes galéniques envisageables. Notamment, la composition peut avoir la forme de solution aqueuse, alcoolique, hydroalcoolique ou huileuse; de dispersion du type lotion ou sérum; d'émulsion eau-dans-huile, huile-dans-eau ou multiple; de suspension; de microcapsules ou microparticules; de dispersions vésiculaires de type ionique et/ou non ionique; de lotion aqueuse, huileuse ou sous forme de sérum; de capsules, de granulés, de sirops, de comprimés; de mousse, de préparation solide; de composition pour aérosol comprenant également un agent propulseur sous pression.30 Une composition selon l'invention peut se présenter sous la forme d'une composition pour soin capillaire, notamment un shampooing, une lotion de mise en plis, une lotion traitante, une crème ou un gel coiffant, une composition de teinture, notamment d'oxydation, des lotions restructurantes pour les cheveux, une composition de permanente (notamment une composition pour le premier temps d'une permanente), une lotion ou un gel antichute, un shampooing antiparasitaire. Elle peut également se présenter sous la forme d'une composition de nettoyage, de protection, de traitement ou de soin pour le visage, pour les mains, pour les pieds, pour les grands plis anatomiques ou pour le corps (par exemple crèmes de jour, crème de nuit, crème démaquillante, composition antisolaire, lait corporels de protection ou de soin, laits après-solaire, lotion, gel ou mousse pour le soin de la peau, comme des lotion de nettoyage, composition de bronzage artificiel); une composition de maquillage du corps ou du visage telle qu'un fond de teint; une composition pour le bain; une composition désodorisante comprenant par exemple un agent bactéricide; une composition après-rasage; une composition épilatoire; une composition contre les piqûres d'insectes; une composition anti-douleur ; une composition dermatologique ou pharmaceutique pour traiter certaines maladies de la peau comme l'eczéma, la rosacée, le psoriasis, les lichens, les prurits sévères. Lorsqu'une composition selon l'invention est destinée à un usage de type peeling, elle peut également se présenter sous toutes les formes galéniques évoquées ci-dessus pour autant qu'elle s'élimine facilement par rinçage, et notamment sous forme de gel aqueux, de solution aqueuse ou hydroalcoolique. Une composition selon l'invention peut être appliquée par tout moyen permettant une répartition uniforme et notamment à l'aide d'un coton, d'une tige, d'un pinceau, d'une gaze, d'une spatule ou d'un tampon, ou encore par pulvérisation, et peut être éliminée par rinçage à l'eau ou à l'aide d'un détergent doux. Une composition selon l'invention peut se présenter sous une forme fluide de 5 type liquide vaporisable ou non, sous forme de pâte, de gel ou de support imprégné, sous forme solide, notamment compacte, pulvérulente ou coulée ou sous une forme de stick. Une composition selon l'invention peut également se présenter sous la forme 10 d'un produit de soin, d'un produit solaire ou après solaire, d'un produit de soin de photo-protection quotidienne, d'un produit pour le corps, d'un fond de teint à appliquer sur le visage ou sur le cou, d'un produit anti-cernes, d'un correcteur de teint, d'une crème teintée ou d'une base de maquillage pour le maquillage pour le visage ou d'une composition de maquillage pour le corps. 15 Une composition selon l'invention peut être mise en oeuvre à des fins d'amélioration de l'état général d'un épiderme, en particulier de la peau, et notamment pour le maintient ou la restauration de ses fonctions physiologiques et/ou de son aspect esthétique. 20 Ainsi, une composition selon l'invention peut être avantageusement mise en oeuvre afin de lutter contre le vieillissement de l'épiderme, maintenir et/ou stimuler l'hydratation et/ou lutter contre le dessèchement de la peau, améliorer la tonicité de la peau, maintenir ou restaurer la souplesse et l'élasticité de la 25 peau, améliorer la minéralisation de l'épiderme, améliorer la vitalité de l'épiderme, faciliter les échanges inter-cellulaires, et lutter contre les gerçures et l'aspect craquelé de la peau. Une composition selon l'invention peut être destinée à une application 30 cosmétique et/ou dermatologique.A composition of the invention may be in any conceivable galenic form. In particular, the composition may have the form of aqueous, alcoholic, hydroalcoholic or oily solution; dispersion of the lotion or serum type; water-in-oil, oil-in-water or multiple emulsion; suspension; microcapsules or microparticles; vesicular dispersions of ionic and / or nonionic type; aqueous, oily or serum lotion; capsules, granules, syrups, tablets; foam, solid preparation; composition of an aerosol composition also comprising a propellant under pressure. A composition according to the invention may be in the form of a composition for hair care, in particular a shampoo, a styling lotion, a treatment lotion or a cream. or a styling gel, a dyeing composition, in particular an oxidation composition, restructuring lotions for the hair, a permanent composition (in particular a composition for the first time of a perm), a lotion or an anti-fall gel, a pest control shampoo . It may also be in the form of a composition for cleaning, protecting, treating or caring for the face, the hands, the feet, the large anatomical folds or the body (for example, day creams). , night cream, make-up remover, sunscreen composition, body protection or care milk, after-sun milks, lotion, gel or mousse for skin care, such as cleaning lotion, artificial tanning composition); a makeup composition for the body or the face such as a foundation; a bath composition; a deodorant composition comprising, for example, a bactericidal agent; aftershave composition; an epilatory composition; a composition against insect bites; an anti-pain composition; a dermatological or pharmaceutical composition for treating certain skin diseases such as eczema, rosacea, psoriasis, lichens, severe pruritus. When a composition according to the invention is intended for use as a peel, it may also be in any of the galenical forms mentioned above, provided that it is easily removed by rinsing, and in particular in the form of an aqueous gel. of aqueous or hydroalcoholic solution. A composition according to the invention may be applied by any means allowing a uniform distribution and especially using a cotton, a rod, a brush, a gauze, a spatula or a buffer, or by spraying, and may be removed by rinsing with water or a mild detergent. A composition according to the invention may be in a fluid form of liquid type vaporizable or not, in the form of paste, gel or impregnated support, in solid form, in particular compact, pulverulent or cast or in a stick form. A composition according to the invention may also be in the form of a care product, a solar product or after sun, a daily photoprotective care product, a product for the body, a foundation to be applied to the face or neck, a concealer, a concealer, a tinted cream or a makeup base for face makeup or a makeup composition for the body. A composition according to the invention may be used for the purpose of improving the general condition of an epidermis, in particular the skin, and in particular for maintaining or restoring its physiological functions and / or its aesthetic appearance. Thus, a composition according to the invention can be advantageously used in order to fight against aging of the epidermis, maintain and / or stimulate hydration and / or fight against drying of the skin, improve the tone of the skin. skin, maintain or restore the suppleness and elasticity of the skin, improve the mineralization of the epidermis, improve the vitality of the epidermis, facilitate inter-cellular exchanges, and fight against chapped and cracked appearance of the skin; the skin. A composition according to the invention may be intended for a cosmetic and / or dermatological application.
D'autres caractéristiques et avantages de l'invention ressortiront mieux des exemples qui suivent, donnés à titre illustratif et non limitatif. Dans ce qui suit ou ce qui précède, les proportions sont données en pourcentage pondéral, sauf indications contraires.Other characteristics and advantages of the invention will emerge more clearly from the examples which follow, given by way of illustration and not limitation. In what follows or what precedes, the proportions are given in percentage by weight, unless otherwise indicated.
Exemples 1 à 5: On a réalisé une émulsion H/E (exemple1) comprenant une huile polaire selon l'invention et 3 émulsions (exemples 2 à 4) comparatives comprenant des huiles hors invention, et on a observé la stabilité de ces compositions. 1 2 3 4 5 Alcool cétylique 1,7 1,7 1,7 1,7 1,7 Alcool béhénylique 1,5 1,5 1,5 1,5 1,5 Acide stéarique 1,1 1,1 1,1 1,1 1,1 Mélange d'alcools en C14-C22 et C14-C20 alkylglucoside (80/20) (MONTANOV 68® de SEPPIC) 0,6 0,6 0,6 0,6 0,6 POLOXAMER 338 0,4 0,4 0,4 0,4 0,4 (Synperonic PE/F 108 de CRODA) PEG-100 STEARATE 0,2 0,2 0,2 0,2 0,2 (Myrj S100-PA de CRODA) PPG-15 STEARYL ETHER (Arlamol® PS15E de CRODA) 3 PENTAERYTHRITYL TETRAETHYLHEXANOATE (DUB PTO de STEARINERIE DUBOIS) 3 Phase Al A2 C12-15 ALKYL BENZOATE (DUB B1215 de STEARINERIE DUBOIS) 3 CAPRYLIC/CAPRIC TRIGLYCERIDE (DUB MCT 7030 de STEARINERIE DUBOIS) 3 PPG-3 MYRISTYL ETHER (TEGOSOFT APM de EVONIK GOLDSCHMIDT) 3 A3 ISOPROPYL ISOSTEARATE 2,6 DIMETH ICONE 350 CST (BELSIL DM 350 de WACKER) 0,5 Octyldodécanol 3 CAPRYLOYL SALICYLIC ACID 0,3 Conservateurs 0,9 Adenosine 0909 de CHENG YI PHARMACEUTICAL) 0,1 B Eau 25 Glycérine 8 DISODIUM EDTA 0,1 C Eau QSP 100% D Sel de sodium de l'acide 3- hydroxy-2-pentyl-cyclopentane acétique à 30 % dans un mélange eau/dipropylène glycol (70/30). 6,7% (2%MA) E DIMETHICONE 6 CST (Xiameter PMX-200 Silicone 6,6 Fluid 5CS de DOW CORNING) CARBOMER (Carbopol Ultrez 10 Polymer de LUBRIZOL) 0,5 Homopolymère d'acide acrylamidométhyl propane sulfonique réticulé (HOSTACERIN AMPS® de CLARIANT) 0,8 SODIUM HYALURONATE (Cristal Hyal de SOLIANCE) 0,1 F Hydroxyde de sodium en solution aqueuse à 30% de matière active qs pH 6 G Mélange (50/50 en poids) de Cire de poly tétrafluoro éthylène (Fluoropure 103 C de SHAMROCK TECHNOLOGIE et de Polyéthylène( Micropoly 220 L de MICRO POWDERS) 2 Mode Opératoire : - Peser toutes les MPs de A ensemble et chauffer vers 75°C-80°C sous Rayneri - Solubiliser B à température ambiante sous agitation magnétique - Émulsionner B dans A sous agitation forte - Ajouter la phase de dilution C - Ajouter D - Ajouter E (empâter les gélifiants dans la silicone sous Rayneri) - Ajouter F - Ajouter G 1 2 3 4 5 (invention (invention ) ) Tension superficielle phase A2 30m N/m 28,9mN/ m 32mN/m 29m N/m 30m N/m Stabilité 1 mois 45°C et 4°C Stable Recristalli Recristallis Recristalli Stable Fine sation du ation du sation du Fine dispersion dérivé dérivé dérivé dispersion homogène d'acide d'acide d'acide homogène cucurbiqu cucurbique cucurbiqu e à 4°C à 4°C e à 4°C Les compositions selon l'invention (ex 1 et 5) contenant le sel de sodium de l'acide 3-hydroxy-2-pentyl-cyclopentane acétique et l'huile polaire (poly)oxypropylénée sont stables et homogènes au moins 1 mois à 4°C et à 45°C, tandis que les compositions comprenant une huile hors invention ne contenant de groupes oxyalkylénés ne sont pas stables, ni homogènes. Les compositions 1 et 5 sont homogènes, lisses, brillantes et s'étalent facilement sur la peau, sans sensation de collant ni de gras, et sans peluchage. Les compositions 2 ,3 et 4 sont mates et ne sont pas homogènes.Examples 1 to 5: An O / W emulsion (Example 1) comprising a polar oil according to the invention and 3 comparative emulsions (Examples 2 to 4) comprising oils outside the invention, and the stability of these compositions was observed. 1 2 3 4 5 Cetyl Alcohol 1.7 1.7 1.7 1.7 1.7 Behenyl Alcohol 1.5 1.5 1.5 1.5 1.5 Stearic Acid 1.1 1.1 1.1 1,1 1,1 Mixture of alcohols C14-C22 and C14-C20 alkylglucoside (80/20) (MONTANOV 68® from SEPPIC) 0.6 0.6 0.6 0.6 0.6 POLOXAMER 338 0, 4 0.4 0.4 0.4 0.4 (Synperonic PE / F 108 from CRODA) PEG-100 STEARATE 0.2 0.2 0.2 0.2 0.2 (Myrj S100-PA from CRODA) PPG -15 STEARYL ETHER (Arlamol® PS15E from CRODA) 3 PENTAERYTHRITYL TETRAETHYLHEXANOATE (DUB PTO from STEARINERIE DUBOIS) 3 Phase A1 A2 C12-15 ALKYL BENZOATE (DUB B1215 from STEARINERIE DUBOIS) 3 CAPRYLIC / CAPRIC TRIGLYCERIDE (DUB MCT 7030 from STEARINERIE DUBOIS) 3 PPG-3 MYRISTYL ETHER (TEGOSOFT APM from EVONIK GOLDSCHMIDT) 3 A3 ISOPROPYL ISOSTEARATE 2,6 DIMETH ICON 350 CST (BELSIL DM 350 from WACKER) 0,5 Octyldodecanol 3 CAPRYLOYL SALICYLIC ACID 0,3 Preservatives 0,9 Adenosine 0909 from CHENG YI PHARMACEUTICAL) 0.1 B Water 25 Glycerin 8 DISODIUM EDTA 0.1 C Water QSP 100% D Sodium salt of 3-hydroxy-2-pentyl-cyclopentane acetic acid 30% in a water / dipropylene glycol mixture (70/30). 6.7% (2% MA) E DIMETHICONE 6 CST (Xiameter PMX-200 DOW CORNING 6,6 Fluid 5CS Silicone) CARBOMER (Carbopol Ultrez 10 LUBRIZOL Polymer) 0.5 Acrylamidomethyl propane sulfonic acid crosslinked homopolymer (HOSTACERIN AMPS® from CLARIANT) 0.8 SODIUM HYALURONATE (SOLIANCE Crystal Hyal) 0.1 F Sodium hydroxide in aqueous solution at 30% active ingredient qs pH 6 G Mixture (50/50 by weight) Polytetrafluoroethylene wax (Fluoropure 103 C from SHAMROCK TECHNOLOGY and Polyethylene (Micropoly 220 L from MICRO POWDERS) 2 Procedure: - Weigh all the MPs of A together and heat to 75 ° C-80 ° C under Rayneri - Solubilize B at room temperature with stirring magnetic - Emulsify B in A with strong stirring - Add the dilution phase C - Add D - Add E (Empase the gelling agents in the silicone under Rayneri) - Add F - Add G 1 2 3 4 5 (Invention (invention)) Voltage superficial phase A2 30m N / m 28.9mN / m 32mN / m 29m N / m 30m N / m Stability 1 month 45 ° C and 4 ° C Stable Recrystalli Recristallis Recristalli Stable Fine cation deposition of Fine dispersion derived derivative derived homogeneous homogeneous acid dispersion of cucurbic acid homogeneous cucurbic acid acid at 4 ° C to 4 ° C C at 4 ° C The compositions according to the invention (ex 1 and 5) containing the sodium salt of 3-hydroxy-2-pentyl-cyclopentane acetic acid and polar (poly) oxypropylene oil are stable and homogeneous at least 1 month at 4 ° C. and at 45 ° C., whereas the compositions comprising an oil outside the invention containing no oxyalkylenated groups are not stable or homogeneous. The compositions 1 and 5 are homogeneous, smooth, shiny and spread easily on the skin, without feeling sticky or greasy, and without linting. Compositions 2, 3 and 4 are dull and are not homogeneous.
Exemple 6: On prépare un lait solaire ayant la composition suivante : PPG-15 STEARYL ETHER (ARLAMOL® PS15E de CRODA) 4% Glycérine 5% Sel de sodium de l'acide 3-hydroxy-2-pentyl-cyclopentane acétique à 30 % dans mélange eau/dipropylène glycol (70/30) 2% MA Conservateurs 0.3% C12-15 alkyl benzoate (Tegosoft TN de Evonik/ Goldschmidt) 10% PEG-100 stearate/glycéryl stéarate (Arlacel 165 de de Croda) 5% Gomme de xanthane 0,5% Octocrylene (UVINUL N539 de BASF) 10% Butyl methoxydibenzoylmethane (PARSOL 1789 par la société Hoffmann La Roche ) 3% Ethylhexyl methoxycinnamate (PARSOL MCX de Hoffmann La Roche) 7% Eau qsp 100% Exemple 7: Emulsion hydratante matifiante On prépare la composition suivante : PPG-15 STEARYL ETHER (ARLAMOL® PS15E de CRODA) 4% PEG-30 dipolyhydroxystearate (CITHROL DPHS-S0-(MV) de Croda) 3% Polyglycery1-4 isostearate (Isolan GI34® de Goldschmidt) 1% Dicaprylyl carbonate 6% Polydimethylsiloxane 10 cSt (DOW CORNING SH 200 C FLUID 10 CS de Dow Corning) 2% Vaseline 3% Silice 3% Disteardimonium hectorite 0.4% Glycérine 5% Sel de sodium de l'acide 3-hydroxy-2-pentyl-cyclopentane acétique à 30 % dans mélange eau/dipropylène glycol (70/30) 1,5% MA Conservateurs 0,3% Eau déminéralisée qsp 100% Exemple 8: Lait corporel hydratant On prépare la composition suivante : PPG-15 STEARYL ETHER (ARLAMOL® PS15E de CRODA) 1,5% Sel de sodium de l'acide 3-hydroxy-2-pentyl-cyclopentane acétique à 30 % dans mélange eau/dipropylène glycol (70/30) 1 %MA Conservateurs 0,3% Glycérine 10% PEG-100 stearate/glycéryl stéarate (Arlacel 165 de de Croda) 2% Dicaprylyl carbonate 10% Octyldodécanol 8% Eau déminéralisée qsp 100% Exemple 9: Fond de teint On prépare une composition de fond de teint : PPG-15 STEARYL ETHER (ARLAMOL® PS15E de CRODA) 3% Sel de sodium de l'acide 3-hydroxy-2-pentyl-cyclopentane acétique à 30 % dans mélange eau/dipropylène glycol (70/30) 2.4 % MA Conservateurs 0.3% Glycérine 10% POLYGLYCERYL-4 ISOSTEARATE (and) CETYL PEG/PPG-10/1 5 DIMETHICONE (and) HEXYL LAURATE (ABIL WE 09 de Evonik/ Goldschm idt) 10% Dicaprylyl carbonate 10% Oxyde de fer jaune enrobé 1.6% Oxyde de fer brun enrobé 0.4% 10 Oxyde de fer noir enrobé 0.25% Oxyde de titane enrobé 10% Eau déminéralisée qsp 100% Les compositions des exemples 6 à 9 ci-dessus sont stables.EXAMPLE 6 A solar milk having the following composition is prepared: PPG-15 STEARYL ETHER (ARLAMOL® PS15E from CRODA) 4% Glycerin 5% Sodium salt of 3-hydroxy-2-pentyl-cyclopentane acetic acid 30% in water / dipropylene glycol (70/30) 2% MA preservatives 0.3% C12-15 alkyl benzoate (Evonik / Goldschmidt Tegosoft TN) 10% PEG-100 stearate / glyceryl stearate (Croda Arlacel 165) 5% Gum xanthan 0.5% Octocrylene (UVINUL N539 from BASF) 10% Butyl methoxydibenzoylmethane (PARSOL 1789 by the company Hoffmann La Roche) 3% Ethylhexyl methoxycinnamate (PARSOL MCX from Hoffmann La Roche) 7% Water qs 100% Example 7: Moisturizing emulsion mattifying The following composition is prepared: PPG-15 STEARYL ETHER (ARLAMOL® PS15E from CRODA) 4% PEG-30 dipolyhydroxystearate (CITHROL DPHS-S0- (MV) from Croda) 3% Polyglyceryl-4 isostearate (Isolan GI34® from Goldschmidt) 1 % Dicaprylyl carbonate 6% Polydimethylsiloxane 10 cSt (DOW CORNING SH 200 C FLUID 10 CS Dow Corning) 2% Vaseli 3% Silica 3% Disteardimonium hectorite 0.4% Glycerin 5% Sodium salt of 3-hydroxy-2-pentyl-cyclopentane acetic acid 30% in water / dipropylene glycol (70/30) 1.5% MA Preservatives 0.3% Demineralized water qs 100% Example 8: Moisturizing body lotion The following composition is prepared: PPG-15 STEARYL ETHER (ARLAMOL® PS15E from CRODA) 1.5% Sodium salt of 3-hydroxy-2- acid 30% pentyl-cyclopentane acetic acid in water / dipropylene glycol (70/30) mixture 1% MA Preservatives 0.3% Glycerin 10% PEG-100 stearate / glyceryl stearate (Croda Arlacel 165) 2% Dicaprylyl carbonate 10% Octyldodecanol 8% Demineralized water qs 100% Example 9: Foundation A foundation composition is prepared: PPG-15 STEARYL ETHER (ARLAMOL® PS15E from CRODA) 3% Sodium salt of 3-hydroxy-2-pentyl acid -cyclopentane acetic acid 30% in water / dipropylene glycol (70/30) 2.4% MA preservatives 0.3% Glycerine 10% POLYGLYCERYL-4 ISOSTEARATE (and) CETYL PEG / PPG- 10/1 5 DIMETHICONE (and) HEXYL LAURATE (ABIL WE 09 from Evonik / Goldschm idt) 10% Dicaprylyl carbonate 10% Iron oxide yellow coated 1.6% Coated brown iron oxide 0.4% 10 Coated black iron oxide 0.25% Oxide coated titanium 10% Demineralized water qs 100% The compositions of Examples 6 to 9 above are stable.
15 Les compositions appliquées sur la peau s'étalent facilement, sans sensation de collant ni de gras.The compositions applied to the skin spread easily without feeling sticky or greasy.
Claims (13)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1353508A FR3004641B1 (en) | 2013-04-17 | 2013-04-17 | COSMETIC COMPOSITION COMPRISING A CUCURBIC ACID COMPOUND AND OXYALKYLENE POLY (POLY) OIL |
PCT/FR2014/050901 WO2014170591A1 (en) | 2013-04-17 | 2014-04-14 | Cosmetic composition comprising a cucurbic acid compound and a (poly)oxyalkylenated polar oil |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1353508A FR3004641B1 (en) | 2013-04-17 | 2013-04-17 | COSMETIC COMPOSITION COMPRISING A CUCURBIC ACID COMPOUND AND OXYALKYLENE POLY (POLY) OIL |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3004641A1 true FR3004641A1 (en) | 2014-10-24 |
FR3004641B1 FR3004641B1 (en) | 2016-01-15 |
Family
ID=49237249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1353508A Active FR3004641B1 (en) | 2013-04-17 | 2013-04-17 | COSMETIC COMPOSITION COMPRISING A CUCURBIC ACID COMPOUND AND OXYALKYLENE POLY (POLY) OIL |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3004641B1 (en) |
WO (1) | WO2014170591A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018172360A1 (en) | 2017-03-21 | 2018-09-27 | Calyxia | Method for preparing capsules comprising at least one water-soluble or hydrophilic substance and capsules obtained therefrom |
WO2018172434A2 (en) | 2017-03-21 | 2018-09-27 | Capsum | Method for producing capsules comprising at least one water-soluble or hydrophilic substance, and resulting capsules |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1333021A2 (en) * | 2002-02-04 | 2003-08-06 | L'oreal | Compositions containing derivatives of jasmonic acid and their use for stimulating skin peeling |
DE102006020382A1 (en) * | 2006-04-28 | 2007-10-31 | Henkel Kgaa | Cosmetic oil-in-water emulsion, useful e.g. to treat skin, comprises oil or fat phase comprising a component e.g. branched saturated alkanol, water, a cosmetically active substance e.g. monomer and a polysaccharide |
WO2008038140A2 (en) * | 2006-06-07 | 2008-04-03 | Foamix Ltd. | Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof |
EP2223680A2 (en) * | 2008-12-30 | 2010-09-01 | L'Oréal | Combination of monosaccharides and exfoliating agents and its cosmetic use |
DE102010028585A1 (en) * | 2009-05-12 | 2010-12-02 | Evonik Goldschmidt Gmbh | Multi-phase cosmetic composition |
WO2011077083A1 (en) * | 2009-12-24 | 2011-06-30 | Croda International Plc | Inverse emulsions comprising an alkoxylated ester oil |
FR2964865A1 (en) * | 2010-09-16 | 2012-03-23 | Oreal | Composition, useful for the non-therapeutic treatment of keratin materials and e.g. for treating skin diseases e.g. eczema, comprises at least one cucurbic acid compound, and polyhydroxy fatty acid ester and polyoxyalkylene glycol |
FR2977487A1 (en) * | 2011-07-08 | 2013-01-11 | Oreal | COSMETIC COMPOSITIONS IN THE FORM OF WATER-IN-OIL EMULSIONS COMPRISING A JASMONIC ACID DERIVATIVE AND A SILICONE SURFACTANT |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2796990B2 (en) | 1989-05-10 | 1998-09-10 | 株式会社資生堂 | Skin cosmetics |
EP1798213A1 (en) | 2005-12-14 | 2007-06-20 | Cognis IP Management GmbH | Process for the production of hydrocarbons |
WO2008155059A2 (en) | 2007-06-19 | 2008-12-24 | Cognis Ip Management Gmbh | Hydrocarbon mixtures and use thereof |
FR2921255B1 (en) | 2007-09-21 | 2013-12-27 | Oreal | USE OF A JASMONIC ACID DERIVATIVE AS A DEPIGMENTING AGENT |
-
2013
- 2013-04-17 FR FR1353508A patent/FR3004641B1/en active Active
-
2014
- 2014-04-14 WO PCT/FR2014/050901 patent/WO2014170591A1/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1333021A2 (en) * | 2002-02-04 | 2003-08-06 | L'oreal | Compositions containing derivatives of jasmonic acid and their use for stimulating skin peeling |
DE102006020382A1 (en) * | 2006-04-28 | 2007-10-31 | Henkel Kgaa | Cosmetic oil-in-water emulsion, useful e.g. to treat skin, comprises oil or fat phase comprising a component e.g. branched saturated alkanol, water, a cosmetically active substance e.g. monomer and a polysaccharide |
WO2008038140A2 (en) * | 2006-06-07 | 2008-04-03 | Foamix Ltd. | Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof |
EP2223680A2 (en) * | 2008-12-30 | 2010-09-01 | L'Oréal | Combination of monosaccharides and exfoliating agents and its cosmetic use |
DE102010028585A1 (en) * | 2009-05-12 | 2010-12-02 | Evonik Goldschmidt Gmbh | Multi-phase cosmetic composition |
WO2011077083A1 (en) * | 2009-12-24 | 2011-06-30 | Croda International Plc | Inverse emulsions comprising an alkoxylated ester oil |
FR2964865A1 (en) * | 2010-09-16 | 2012-03-23 | Oreal | Composition, useful for the non-therapeutic treatment of keratin materials and e.g. for treating skin diseases e.g. eczema, comprises at least one cucurbic acid compound, and polyhydroxy fatty acid ester and polyoxyalkylene glycol |
FR2977487A1 (en) * | 2011-07-08 | 2013-01-11 | Oreal | COSMETIC COMPOSITIONS IN THE FORM OF WATER-IN-OIL EMULSIONS COMPRISING A JASMONIC ACID DERIVATIVE AND A SILICONE SURFACTANT |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018172360A1 (en) | 2017-03-21 | 2018-09-27 | Calyxia | Method for preparing capsules comprising at least one water-soluble or hydrophilic substance and capsules obtained therefrom |
WO2018172434A2 (en) | 2017-03-21 | 2018-09-27 | Capsum | Method for producing capsules comprising at least one water-soluble or hydrophilic substance, and resulting capsules |
US11071962B2 (en) | 2017-03-21 | 2021-07-27 | Calyxia | Method for preparing capsules comprising at least one water-soluble or hydrophilic substance and capsules obtained therefrom |
Also Published As
Publication number | Publication date |
---|---|
FR3004641B1 (en) | 2016-01-15 |
WO2014170591A1 (en) | 2014-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2694022B1 (en) | Cosmetic composition including a cucurbic acid compound and a mixture of sulfonic and acrylic polymers | |
FR2830759A1 (en) | COMPOSITION IN THE FORM OF AN OIL-IN-WATER EMULSION CONTAINING A SILICONE COPOLYMER AND ITS IN PARTICULAR COSMETIC USES | |
FR2944289A1 (en) | VOLATILE OIL COMPOSITION | |
FR2948872A1 (en) | COSMETIC COMPOSITION COMPRISING AN OXYALKYLENE DERIVATIVE | |
FR2954125A1 (en) | COSMETIC COMPOSITION COMPRISING A JASMONIC ACID COMPOUND | |
EP2100586B1 (en) | Cosmetic composition comprising an ascorbic acid or salicylic acid compound | |
EP1875893B1 (en) | Composition combining a C-glycoside derivative with an associative polymer | |
FR2964865A1 (en) | Composition, useful for the non-therapeutic treatment of keratin materials and e.g. for treating skin diseases e.g. eczema, comprises at least one cucurbic acid compound, and polyhydroxy fatty acid ester and polyoxyalkylene glycol | |
FR3089122A1 (en) | Composition comprising hectorite and pectin | |
FR2998793A1 (en) | COSMETIC COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION | |
WO2002055039A1 (en) | Cosmetic and/or dermatological acid composition containing an amphiphilic polymer | |
FR3117799A1 (en) | Composition comprising aqueous gelling agents, surfactant, oils, fillers and ascorbic acid | |
FR2958846A1 (en) | ALKALINE CLEANING COMPOSITION COMPRISING AT LEAST 52% BODY FATS AND USES THEREOF | |
FR2977478A1 (en) | Composition, useful for treating keratin materials e.g. hair, skin, mucous membranes, scalp and lips, comprises cucurbic acid compound, and silicone emulsifier e.g. oxyethylenated and oxypropylenated alkylpolydimethylsiloxanes | |
FR2928541A1 (en) | Composition, useful for care/make-up of keratin materials e.g. lips, comprises: fatty acid ester and polyethylene glycol; additional surfactant; polycondensate of ethylene oxide and propylene oxide; and active ingredient e.g. ascorbic acid | |
FR3008611A1 (en) | COSMETIC COMPOSITION COMPRISING A CUCURBIC ACID COMPOUND AND ANIONIC SURFACTANT DERIVED FROM AMINO ACID | |
EP1415645B1 (en) | Composition in the form of an oil-in-water emulsion and its cosmetic uses | |
FR3030272A1 (en) | COSMETIC PROCESS FOR TREATING KERATINIC MATERIALS USING ANHYDROUS COMPOSITION COMPRISING A FATTY BODY AND A MICROEMULSION | |
FR3104977A1 (en) | Retinol based serum | |
WO2014170591A1 (en) | Cosmetic composition comprising a cucurbic acid compound and a (poly)oxyalkylenated polar oil | |
EP2018838B1 (en) | Oil-in-water emulsion containing an amphiphile polymer | |
FR3029780A1 (en) | COMPOSITION COMPRISING HESPERETIN | |
FR2976485A1 (en) | Use of water-dispersible flocculant polymer comprising in side chain of non-quaternary amino groups carried by a side substituent directly attached to a main chain, as an antiperspirant active ingredient | |
FR2928540A1 (en) | Composition, useful for care/make-up of keratin materials e.g. lips, comprises: fatty acid ester and polyethylene glycol; additional surfactant; polycondensate of ethylene oxide and propylene oxide; and active ingredient e.g. ascorbic acid | |
FR3104974A1 (en) | Retinol based serum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 9 |
|
PLFP | Fee payment |
Year of fee payment: 10 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |